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ABSTRACT

In Vitro Anafysis of Integrin Mediated Adhesion,
Migration, and Signaling

by

William L. Rust

Dr. George Plopper, Examination Committee Chair
Assistant Ârofessor of Biological Sciences
University of Nevada, Las Vegas

Integrins are cellular adhesion receptors whose functions are critical to the
progression o f solid tissue cancers. The research described here involves four projects
aimed at understanding how integrins modulate key elements of carcinogenesis,
(adhesion and migration), on laminin basal lamina proteins.
In order to carry out these studies, a novel fluorescence based protocol for quantifying
cell migration towards a bound substrate was developed (Chapter 2). This method is more
reliable, efficient, and informative than currently available protocols. 1demonstrate its
use as a screen for migration-blocking chemotherapeutic drugs.
The small heat shock protein 27 (HSP27) is found to be over-expressed in many
mammary carcinomas and can be an effective prognosticator of disease recurrence
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following treatment. The m echanism s for this action of HSP27 are not folly understood.
In chapter 3,1 demonstrate that over-expressed and activated HSP27 enhances migration
towards laminin-5 in breast carcinoma cells through an intracellular signaling pathway
involving mitogen activated protein kinase (MAPK/ERK 1/2). In addition, non-activated
HSP27 in the same cells confers resistance to a subset of drugs that would halt migration.
In a screen of drugs that block the fonction of specific intracellular signaling
molecules, it was found that an inhibitor of G-protein mediated signaling blocked the
integrin induced migration o f breast epithelial cells on laminin-5.1 demonstrated in
chapter 4 that pro-migratory signaling cascades stimulated by the P 1 class of integrins are
inhibited specifically by interruption of Ga, and not Gets heterotrimeric G-protein
isoforms. Furthermore, p i stimulation caused an increase o f an intracellular G-protein
effector (cAMP). Artificial manipulation of cAMP mimicked the effects of p i
stimulation on migration of these cells. These data suggested for the first time that Gproteins function in integrin stimulated signal cascades.
Because most cells express several types of integrins simultaneously, in chapter 5 1
constructed a model whereby the contribution of individual integrin types to the net effect
o f integrin engagement could be analyzed. For this 1 demonstrated that intracellular
calcium flux can be used as a reliable downstream marker of integrin stimulated signaling
cascades, and that laminin-1 is a good model substrate for stimulating a variety of
integrin subtypes. Next I describe the production and testing of six recombinant
fi-agments of laminin-1 for the purpose of producing activating ligands of specific
laminin-1 binding integrins.
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CHAPTER 1

GENERAL INTRODUCTION
The behavior of ail living cells is controlled by three extrinsic factors. These are the
conditions of the immediate environment (pH, temperature, salinity, osmolality,
irradiation), the static environment (molecules of connective tissue and neighboring
cells), and the soluble environment (mitogens, endocrine and paracrine signals,
hormones). This also holds true for tumorigenic cells of the human body. Regardless of
gene expression patterns or mutations, the progression of human cancers is dependent
upon cellular interactions with the microenvironment. Although much research into
cancer progression has been accomplished, it remains largely unknown how a
tumorigenic cell’s microenvironment enhances or blocks cancer growth. In order to
understand the cumulative effect of these extrinsic factors in controlling the progression
o f human cancers, the impact of each must first be fully understood.
The research described here focuses on understanding the cellular interaction of
normal and tumorigenic epithelial cells with a component of the static environment, the
basal lamina, in exclusion of all other influences. Specifically, the interaction between the
integrin class of adhesion receptors and laminins, the most abundant members of the
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basal lamina [1]. Each chapter describes a project aimed at understanding the specific
intracellular signaling stimulated by integrin engagement to lam inins, or quantifying
integrin-mediated adhesion and migration on laminins.
Integrins are not the only receptors by which cells interact with the static
environment, but are the major receptors by which the cells of solid tissues interact with
the basal lamina [2]. Four other families of adhesion molecules have been identified.
These are the cadherins, the immunoglobulin (Ig) superfamily, selectins, and CD44 [3].
Cadherins are a family of transmembrane glycoproteins that mediate cell-cell adhesion
via homotypic (cadherin to cadherin) interactions and are fundamental determinants of
tissue organization in developing and adult organisms [3-5]. Ig superfamily adhesion
molecules are characterized by the presence of immunoglobulin-like domains. This
family mediates endothelial cell interactions with lymphocytes, monocytes, neutrophils,
and tumor cells that result in adhesion and trans-endothelial migration. Selectins are
transmembrane glycoproteins that mediate heterotypic interactions between blood and
endothelial cells during lymphocyte homing and leukocyte adhesion. CD44 is a widely
distributed integral membrane glycoprotein shown to facilitate lymphocyte homing and
T-cell activation, and is the primary cell surface receptor for hyaluronan [3]. Finally,
integrins are transmembrane heterodimers that are obligatory on the plasma membrane of
every mammalian cell type, and the focus of the majority of cell adhesion research [6].
The importance of integrin function in mammals is evidenced by gene knock-out
studies in mice. Deletion of individual integrin subtypes leads to unique phenotypes with
little overlap, and most deletions are perinatal lethal. In fact, deletion of a class of
integrins (Pl) results in embryonic lethality by day five. [7,8].
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As our understanding o f cancer development grows, it has become clear that the
integrin family of cell adhesion receptors play an important role in virtually every stage
o f cancer progression. Although integrins are not oncoproteins, they help modulate the
processes of cell growth, death, migration, and invasion, which all impinge on the
severity of clinical disease [9]. It is common to find that oncogenic transformation
accompanies changes in integrin expression and substrate preference. Several drugs in
clinical trials fimction as integrin antagonists, all having shown promise as antiangiogenic, anti metastatic, and anti-proliferative compounds in mice models [10-12]. It
is from studies of tumorigenic tissues and cells that much o f our understanding o f integrin
fimction has emerged.

Basal Lamina
The basal lamina are sheets of extracellular matrix (ECM) that line all the cavities and
free surfaces of the body, forming barriers from one body compartment to another. Made
and organized by epithelial cells, the ECM provides an adhesive substrate, transmits
signals through adhesion receptors, and binds, stores, and presents growth factors. During
embryogenesis, the basal lamina fimctions to promote proliferation, differentiation, and
migration of embryonic cells. In adults, the basal lamina fimctions as a molecular filter,
polarizing epithelial cells, shaping the tissue structures, supporting infiltration of
immunocytes, and guiding the migration of regenerating cells following injury [8, 10].
The components of the extracellular matrix are polysaccharide chains of the class called
glycosaminoglycans, structural fibrous proteins (collagen and elastin), and adhesive

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

proteins, (fibronectin and laminin). The polysaccharide chains are usually found
covalently linked to protein in the form of proteoglycans.
Laminins are the first ECM proteins expressed in the developing embryo (2-4 cell
stage), they are the most abundant basal lamina protein, and they are found in every adult
basal lam ina [1,13]. These are a family of heterotrimeric glycoproteins composed of a
single a (~400kDa), P (-200 kDa), and y (~200kDa) chain (figure 1). Diversity within
the laminin family is achieved by forming different combinations of aPy trimers [13].
Currently, twelve lam inin isoforms are known. Each chain is composed of 2-4 N-terminal
globular domains cormected to a large coiled-coil region. The a chains have an additional
C-terminal domain composed of five repeating globular subdomains. The three chains
interact solely at the coiled-coil region, and are stabilized by disulfide bonds, forming an
overall cross-shaped structure [13].
The lam inins of interest for this study are laminin-5 and laminin-1. Laminin-5 is
abundantly expressed in the basal lamina of breast tissue, and is the preferred adhesive
substrate of many breast carcinoma cells. In addition to being expressed as several splice
variants, lam inin-5 is modified in vivo by proteases which recognize cleavage sites on the
a and y short arms [14]. Modification of this isoform is shown to alter the migratory and
invasive properties of tumorigenic epithelial cells and is found at the leading edge of
metastatic invasion [13]. Laminin-1 is the first discovered and best studied of all the
laminin isoforms. It is isolated from murine Engelbreth-Holm-Swarm (EHS) cells and is
commercially available. This isoform is used in our studies as a model substrate for that
research advantage.
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Integrins
Integrins are the Major Class o f ECM receptors
Integrins mediate adhesion to extracellular matrix proteins and, in a few cases, cell
cell adhesion. There are currently 18 a and 8 p subunits known which interact to form at
least 24 ap heterodimers. Most cells express more than one integrin isomer, which are
loosely distributed over the cell’s surface. Integrin expression is different between cell
type, and changes with developmental stage and physiological conditions within a cell
type [15,16]. This family of receptors can be classified into three subfamilies. The pl
integrins generally mediate interactions between cells and ECM. The P2 integrins are
restricted to leukocytes and are typified by having other cell surface proteins as their
ligands. The P3 integrins are almost exclusively expressed on platelets and
megakaryocytes and act as important mediators of platelet adhesion [6].
Excepting the fibronectin receptor a 5 p i, all integrins recognize and bind to more
than one ECM molecule. Each ECM molecule is also known to be bound by more than
one integrin. Although it is impossible to predict an integrin binding site based on
sequence, an acidic residue is common to all known binding sites, and many contain the
sequence RGD [12].
Integrins on resting cells do not adhere strongly to their ligands, but are rapidly and
reversibly activated by cellular agonists. The affinity of integrins for their ligand is
enhanced by conformational changes to their dimeric structure. Adhesive strength is
increased through lateral clustering of integrins at points of cellular contact, a process
termed avidity [6,17].
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Integrins are heterodimeric glycoproteins
Both a and P subunits are composed of a large, stalk like C-terminal extracellular
domain, a single transmembrane segment (-20 aa), and with the exception of P4, a small
(-250aa) globular cytoplasmic domain stabilized by intrapeptide disulfide bonds. The a
chain globular head is composed of a sub-domain of seven homologous 60aa repeats that
are predicted to form a P propeller structure containing three or four EF hand type
divalent cation binding motifs. Nine a subunits have an additional domain termed the 1
domain which is the site o f a Mg/Mn metal ion-dependent adhesion site (MIDAS) [12,
17,18]. In addition, all integrin a subunits contain a highly conserved KXGFFKR motif
adjacent to the transmembrane domain that is the proposed binding site for several
integrin binding proteins [19,20]. All p chains have a conserved N-terminal globular
domain of -240aa which is similar to the a 1 subdomain. The p 1-like domain contacts
the p-propeller domain of the a chain and is responsible for the association between the a
and p chains through stabilizing salt bridges involving the cation binding motifs [12,17].
Although exceptions are easily found, the extracellular domain of the a chain is
thought to confer ligand specificity, while the cytoplasmic domain of the p chain is
implicated as the major binding site for interacting cytosolic proteins [12,19]. Two of the
cytosolic proteins that are thought to regulate the activation state of the extracellular
domains are the Ras family of GTPases and protein kinase C (PKC) [6,21]
A common, although unproven, model for integrin activation presumes that ligand
recognition involves the close association of the C-termini of the a and P subunits. Like
the action of opening scissors, this forces a break in the salt bridges holding the
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cytoplasmic domains in contact, opening up binding sites for integrin associated
cytoplasmic proteins [IS].
At sites of integrin activation and clustering, protein aggregates termed focal
complexes and focal adhesions assemble on the intracellular surface. The types of
proteins that form these complexes can be grouped as either structural, which form links
to the actin cytoskeleton, or signaling, which include a variety of kinases and adapter
molecules linking integrins to still more kinases, members of the GTPase families,
phosphoinositide signaling, and ion release (Fig. 2) [20,22,23]. The structural
components are talin, a-actinin, vinculin, and filamin. Talin, a-actinin, and vinculin are
capable of binding F-actin, while filamin is an actin filament cross linking protein. O f
these, only a-actinin is shown to bind directly to integrins, while the others are capable of
binding each other and members of the signaling component [18,24,25]. These
complexes are sites where the cell can generate tension with respect to its surroundings,
allowing the cell to alter its shape and carry out complex processes such as migration and
cell division [12,26].
The signaling proteins found at focal complexes and focal adhesions associate with
integrin cytoplasmic domains to form a nexus for stimulating intracellular signaling
cascades. At these sites, signaling fi’om outside to inside the cell occurs which contributes
to the regulation of diverse cellular processes including entry into the cell cycle and
programmed cell death (apoptosis), gene transcription, regulation of intracellular pH,
differentiation, and migration. Signaling through integrins from the inside to the outside
of the cell regulates adhesive strength through affinity and avidity modulation, and helps
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Figure 2. Model o f signaling complex (A), and structural complex (B)
formed at focal adhesions.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

10
in remodeling of the extracellular matrix in the processes of tissue development and
tissue invasion.
Integrins are signaling receptors
Outside-in
Except that integrins have no intrinsic enzymatic activity, there is little justification
for drawing a distinction between integrin and soluble factor receptor signaling [6,15].
Nearly all intracellular signaling events stimulated by growth factors can be at least
transiently stimulated by integrins. In fact, many mitogenic responses, including
activation of the mitogen activated protein kinases (MAPKs) require integrin activation
for a strong or sustained response [27].
Most attention placed on integrin linked signaling focuses on the 125kDa kinase
termed focal adhesion kinase (FAK). Although FAK lacks Src homology (SH2 and SH3)
binding domains and the ability to anchor to the membrane, it has numerous tyrosine and
serine/threonine phosphorylation sites that act as docking sites for the recruitment and
activation of several SH2- and SH3-containing classes of signaling molecules. The FAK
regulated signaling complexes form a complicated, and seemingly redundant association
of adapter molecules that stimulate overlapping signal cascades (Fig. 2) [20,28]. Talin
and paxillin are implicated in the activation of FAK by stimulating its
autophosphorylation on Y397. This opens a binding site for the oncoprotein Src. All three
of these molecules are implicated in targeting FAK to the focal adhesion. Src also
phosphorylates FAK on a number of residues, including Y925. Grb2 binds this motif, and
through the action of the guanine nucleotide exchange factor SOS, connects activated
receptor tyrosine kinases to Ras/ERK/MAP kinase cascades, [12,23,28,29].
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Phosphatidyl Inositol 3-Kinase (PI-3K) also binds to Y397, and mediates cell
proliferation, cell migration, and apoptosis through its downstream effector PKB/Akt [16,
21]. P130CAS is an adapter molecule containing SH2 and SH3 binding motifs that also
binds to FAK and is phosphorylated by FAK/Src. P130cas is implicated in activating the
ERK cascade as well as Jun N-terminal kinase (JNK). Both pl30Cas and FAK, through
the ERK pathway, are implicated in the activation of several transcription factors [29].
FAK is also implicated in preventing apoptosis through a pathway involving PKC,
phospholipase A2 (PLA2), and p53, and in controlling cell cycle progression [27,29].
Integrin regulated signaling proteins that can be activated independent of FAK
include protein kinase C (PKC), integrin linked kinase (ILK), integrin associated protein
(lAP) and the tetraspan (TMS4F) adapter proteins [12,28]. ILK’s only known substrate
is integrins, and may function as a bridge to FAK [12]. Although tetraspans can regulate
cell motility, their mechanism of action is not understood [30].
Inside-out
The main consequence of inside out signaling is changes in integrin adhesive strength
through affinity and avidity modulation. Exactly how this occurs is unknown, but
phosphorylation of integrin subunits may be important in both processes [6]. Intracellular
calcium is shown to decrease integrin affinity while Ras family GTPases can convert
integrins to a high or low affinity state, depending on the cell type [21]. PKC is thought
to cause the increase of both integrin affinity and integrin avidity [6].
Integrins Contribute to Cancer Progression
Solid tissue cancers begin as benign aggregates of poorly differentiated cells which
have, through a range of possible mutations, lost the normal mechanisms regulating cell
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growth and/or cell death. Although not well studied, integrins are shown to influence
proliferation through cooperation with growth factor receptors, by specifically causing
the transcription of the cyclins and cyclin dependent kinases (Cdks) required for
transition past the G1 checkpoint, and by down-regulation o f Cdk inhibitors [6,12,27].
Progranuned cell death, or apoptosis, is regulated by the action of death effector
molecules and resistance mechanisms that counteract the pro-apoptotic signals. The
ultimate apoptosis effectors are the caspase family of proteases [12]. The fact that most
cells deprived o f ECM interactions undergo apoptosis, and that integrin ligation can
rescue those cells demonstrates that integrins are involved in stimulating the apoptosis
resistance mechanisms [12]. Proteins known to be part of those resistance mechanisms
include MAPK, NFkB, Bcl-2, Pl-3 kinase, INK and PKB/Akt. In some cell lines,
integrins are shown to activate the Bcl-2 gene, while others report that integrins increase
the activity of MAPK, JNK, PI-3 kinase, and PKB/Akt [6,12,16,21]. In addition,
integrin dependent interaction with the ECM can suppress the activity of caspase-1 [6].
Lastly, cell death by deprivation of engagement of ECM (anoikis) may be an important
control mechanism in cancer since carcinoma cells that lose contact with the matrix
would die rather than circulate and colonize distant sites [16,21].
Benign tumors are encapsulated by an organized lattice o f basement membrane
components. The progression to malignancy, and the clinical diagnosis of malignant
disease, is essentially determined by the capability of tumor cells to dissociate, degrade
the lattice, and metastasize to other locations within the body. This process, termed the
metastatic cascade, begins with the detachment of single tumor cells and active
infiltration by those cells to the surrounding stroma where entry into the vasculature and
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lymphatic system is possible. Dissociation of individual cells from a tumor mass is
regulated by the E-cadherin family of receptors. These are shown to be suppressors of
epithelial tumor metastasis. Recently, activation of integrin o3p 1 was shown to downregulate E-cadherin mediated adhesion, causing loss of cell-cell adhesion, junctional
communication, and enhancing invasiveness of malignant tumor cells [4].
For invasion by dissociated cells to occur, the ECM that surrounds the neoplastic
tissue must be degraded to allow the escape of invasive cells. Integrins participate in the
ECM degradation by stimulating the secretion of ECM-degrading proteases. Integrin
expression is shown to cause the secretion of the matrix metalloprotease (MMP) family
of proteases in vitro, and enhance invasion in vivo, through a signaling cascade involving
Ras[12,21].
Integrins effect the active migration of cells in the following manner: Membrane
protrusions (lammelipodia and filopodia) are formed at the leading edge of migrating
cells which attach to the substrate by forming focal complexes. The integrin-stimulated
signaling molecules conclusively shown to regulate the formation of lammelipodia and
filopodia are Rac and Cdc42, while Rho is shown to inhibit the formation of these
structures by forming and maintaining stable actin stress fibers. At the trailing end, focal
adhesions are disassembled with the help of calpain and gelsolin, and the integrins are
recycled to the leading edge. Movement of the cell body is accomplished by contraction
of the actin-myosin cytoskeleton which is also triggered by integrin stimulated signal
cascades [5,21,26,31,32]. The rate of cell migration can be plotted as an approximate
bell curve versus the extent of cell adhesion. With low-strength integrin binding,
migration is relatively slow because weakly attached cells do not generate enough
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traction to move significantly. An optimal rate of migration is achieved with increasing
adhesion, and further cell attachment impairs motility by binding the substrate too
strongly to allow efficient movement [33].
Once in the vasculature, cells are trapped in the microvessels o f target organs. For this
reason, the lung, liver, kidney, and lymph nodes are common sites o f metastasis for most
tumors. Once trapped, a percentage of these cells will cross the endothelial cell barrier
and, through an act of ECM remodeling and migration as discussed above, invade the
host tissue. These cells can be killed by the immune system or remain donnant for many
years. Following stimulation by unknown factors, these cells may exit dormancy, begin
to divide, recruit blood vessels, and form a secondary tumor.
Mechanisms o f integrin function are notfully understood
Although much investigation into the mechanisms of integrin function has been
accomplished, it remains unknown how signaling specificity by members of this receptor
family is achieved. In other words, it is unknown how a few engaged integrin subtypes
can regulate the complex behaviors described. It is my hypothesis that, with some
overlap, engagement to ECM can stimulate signaling cascades specific to each integrin.
This can cause a dynamic intracellular signaling response through mechanisms of
integrin crosstalk. Specifically, I hvix)thesize that laroinin binding integrins are capable
of independently and sim ultaneously stimulating several intracellular signal cascades that
cooperate with one another to regulate the strength of adhesion and rate of mieration. The
research described in each of the following four chapters either supports this hypothesis,
or provides a method for studying these phenomena.
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The following chapter describes a novel protocol for quantifying integrin mediated
cell migration. This protocol provides a simpler, more efficient, and more reliable method
than previously available. The protocol is presented as a means for measuring the antimigratory effect of current and experimental anti-cancer chemotherapies. Because most
chemotherapies are cytotoxic, and general cellular cytotoxicity is likely to influence cell
migration, the protocol includes a simultaneous quantification of cell death amongst the
population of cells that have failed to migrate.
Chapter three investigates the influence of heat shock protein 27 (HSP27) on integrin
mediated cell migration. HSP27 is a small chaperonin protein implicated in resistance to
apoptosis and disease recurrence following chemotherapy. I show that activation of
constitutively over-expressed HSP27 enhances migration of a malignant breast cell line
in vitro and induces resistance to a subset of drugs that inhibit integrin-stimulated
migration on the ECM protein laminin-5.
Chapter four provides evidence of a link between pi-containing integrins and
heterotrimeric G-proteins in the stimulation of breast cell migration on the ECM protein
lam inin-5- Previous to this study, heterotrimeric G-proteins had not been implicated in

pro-migratory integrin-stimulated signaling cascades. The involvement of this class o f
signaling molecules is demonstrated through the use of specific inhibitors of
heterotrimeric G-proteins, artificial modulation of the G-protein effector molecule cAMP,
and integrin stimulating antibodies.
In chapter five I build a model to identify mechanisms of integrin cooperation that
have the potential of instilling this class of signaling molecules with the specificity
required for modulating the variety of effects attributed to them. I describe the production
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of recombinant fragments of laminin-1 for the purpose of creating proteins that
specifically stimulate individual laminin-1 binding integrin subtypes. In addition, the
usefulness of intracellular calcium flux as an indicator of integrin cooperation is
demonstrated.
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CHAPTER 2

SCREENING ASSAY FOR PROMIGRATORY/
ANTIMIGRATORY COMPOUNDS

This chapter has been published in Analytical Biochemistry and is presented in the style
o f that journal. The complete citation is:
Rust, W.L., Huff, J.L., Plopper, G.E. 2000. Screening Assay for
Promigratory/Antimigratory compounds. Analytical Biochemistry 280, ppl 1-19.

Abstract
Large scale screening strategies aimed at finding anti-cancer drugs traditionally focus
on identifying cytotoxic compounds that attack actively dividing cells. Because
progression to malignancy involves acquisition of an aggressively invasive phenotype in
addition to hyperproliferation, simple and effective screening strategies for finding
compounds that target the invasive aspects of cancer progression may prove valuable for
identifying alternative and preventative cancer therapies. Here, we describe a
fluorescence based automated assay for identifying anti-migratory compounds, with the
ability to discern cytotoxic from non-cytotoxic modes of action. With this assay, we
analyzed the effects of two drugs on tumorigenic (MDA-MB-435 ) and non-tumorigenic
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(MCF-IOA) human breast cell lines. We chose to compare carboxyamido-triazole (CAI),
an experimental compound shown to inhibit migration of various cell types, with
tamoxifen, a common preventative and therapeutic anti-cancer compound. Our assay
demonstrated that both these compounds inhibit migration at sub-lethal concentrations.
Furthermore, CAI was more effective than tamoxifen at inhibiting chemotactic and
h^totactic migration of both cell lines at all concentrations tested.

Introduction
Cancer progresses in two general stages. It begins as a carcinoma of clonal,
hyperproliferating cells confined to the tissue o f origin, which may exist for years as a
benign, primary tumor. The conversion of a benign tumor to malignancy involves the
acquisition of an aggressively invasive phenotype, wherein the cancer cells leave the
tissue of origin and establish new tumor métastasés at distant sites. Métastasés are first
evident at local lymph nodes, with the severest patient prognosis associated with
métastasés located at distant sites (1).
There are limitations to common chemotherapy regimens. The most conunon drugs
for treating solid tissue cancers are cytotoxic compounds that interfere with the synthesis
or function of nucleic acids. These drugs target actively dividing cells of established
tumorigenic colonies (2). While many are effective at treating earlier stage cancers, none
are curative for later stage disease, when overt métastasés are already evident. Because
many tumors are not diagnosed until advanced stages, the effectiveness of these drugs is
limited (3). In addition, these anti-proliferative agents produce damage to normal tissues,
such as immune suppression, mucositis, and hair loss, as well as side effects such as
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nausea and vomiting (2,4). It is important, therefore, to identify alternative, and
potentially less toxic treatments for halting the spread of cancer. These strategies focus on
preventing the conversion o f tumorigenic cells to the m alignant phenotype, as opposed to
arresting cell growth. For example, recent chemotherapeutic advancements include the
introduction of compounds with non-cytotoxic mechanism s of action, such as antiangiogenic factors, growth factor antagonists, interferons, and agents that induce cellular
differentiation (5-8). These non-cytotoxic compounds will potentially be used to prevent
the spread of cancer, as well as to increase the effectiveness o f cytotoxic drugs. Since the
conversion from hyperproliferative to invasive disease typically takes many years, a large
window exists for the use o f preventative therapies (1,3).
The cellular changes required for malignant conversion are complex, offering a large
and diverse array of potential targets for the development of anti-metastatic drugs. A
common theme among these cellular changes is aberrant regulation of cell migration.
Examples of these changes include secretion of proteases, decreased synthesis of protease
inhibitors; loss of cell-cell contacts; modifications of cell-substrate interactions; and
alteration in the response to and production of chemotactic and haptotactic stimuli during
tumor induced angiogenesis and/or metastasis (reviewed in 9, 10, 11). The identification
of compounds that halt cell migration without inducing cell death may lead to creation of
novel compounds that are less toxic than common anti-proliferative agents (3).
Carboxyamido-triazole (CAI) is an example of such an anti-migratory compound,
which is currently in stage 2 clinical trials of androgen-independent prostate cancer (12).
CAI is an inhibitor of non-voltage gated calcium chaimels and blocks cell migration or
invasion in breast cancer cell lines (13), prostate cancer cell lines (14), ovarian cancer cell
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lines (3), and head and neck squamous cell carcinomas (15). The anti-proliferative effect
of CAI is cytostatic, not cytotoxic, as cells will recover after the removal of CAI (14,16).
This indicates that CAI inhibits signal cascades specific to migration and proliferation.
Established modes of action for CAI include inhibition of nucleotide metabolism by
depleting phosphoribosyl pyrophosphate (16), inhibition of arachidonic acid and
phophoinositide generation (17), and reduction of matrix metalloproteinase activity (13,
18).
While compounds such as CAI hold promise for effective cancer therapy, there is a
lack of screening strategies aimed at identifying these non-cytotoxic, anti migratory
compounds. Here we present a fluorescence based, high-throughput method for screening
potential anti-migratory compounds that is designed to discern cytotoxic fi’om noncytotoxic mechanisms of action. Using 96 and 24 well migration filter plates with
fluorescence-opaque filters, we show that cell migration can be quantitated easily and
reliably with the use of the fluorescent dye calcein-AM. Cytotoxicity of compounds
tested is determined by labeling non-migrated cells with the fluorescent DNA intercalator
propidium iodide. The experimental cells are doubly labeled so that migration and
cytotoxicity are measured in the same assay. The use of a high throughput format, and the
novel incorporation of screens for both anti-migration and cytotoxicity on the same test
cells, represents major improvements in efficiency and cost over traditional trans-filter
migration assays.
With this method, we analyzed the effects of CAI and the well-established anti-breast
cancer compound tamoxifen on migration and viability of two human breast cell lines.
Both compounds inhibited migration of the breast cancer cell line MDA-MB-435 and the
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non-tumorigenic breast ceil line MCF-lOA at sub-cytotoxic concentrations. Our assay
demonstrated that, while MDA-MB-435 cells showed resistance to CAI induced cell
death, CAI inhibited h^totactic and chemotactic migration of both cell lines more
effectively than tamoxifen.

Material and Methods
Materials
MTT (3-[4,5-Dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide; Thiazolyl blue)
was purchased from Sigma-Aldrich Chemicals (St. Louis, MO). Calcein-AM was
purchased from Molecular Probes (Eugene, OR). Tamoxifen citrate was purchased from
Calbiochem-Novabiochem (La Jolla, CA). Carboxyamido-triazole (CAI) was a generous
gift of Dr. Elise C. Kohn (Laboratory of Pathology, National Cancer Institute, National
Institutes of Health, Bethesda, MD). 96 well fluorescence blocking migration plates were
provided by Polyfiltronics (Rockland, MA). 24 well fluorescence blocking migration
plates were a generous gift of Dr. Nancy Chung-Welch, Becton Dickinson (Bedford,
MA). Information regarding the commercial availability of the 24 and 96 well
fluorescence blocking migration plates can be found at the Becton Dickinson website
(www.bd.com/labware/newprod/fluoroblok.html). Transwell migration plates were
purchased from Costar (Cambridge MA).
Tissue Culture
MCF-lOA and MDA-MB-435 cells were maintained as previously described (19).
Cells were routinely passaged using trypsin/EDTA (Irvine Scientific).
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Transwell Migration Assay
Migration assays were conducted as previously described (20), with the following
modifications. Transwell filters (8.0 pm pore size. Costar, Cambridge MA) were coated
with purified bovine fibronectin, mouse laminin-1 and collagen IV at 20pg/ml in
carbonate buffer (pH 9.3), for one hour at room temperature. 120,000 cells were
suspended in DME with 292pg/ml L-Glutamine, 100 units/ml penicillin g, 100 mg/ml
streptomycin sulfate (GPS, Irvine Scientific, Santa Ana, CA) and 1 mM sodium pyruvate
(Gibco BRL, Grand Island, NY), plated on the uncoated side of the filter and incubated in
a humidified incubator containing 5% CO2 Filters were washed twice in phosphate
buffered saline (PBS) and the uncoated side of each filter was wiped with a cotton tipped
applicator to remove cells that had not migrated. Cells were then fixed in 3.7%
formaldehyde for 15 minutes, and stained with crystal violet as in the adhesion assay.
Stained cells of four representative fields of each filter were counted at 400X
magnification.
96 and 24 Well Fluorescence Migration Assay
An individual filter insert and well of a 24 or 96 well migration plate is indicated in
Fig. 1. Both 24 well and 96 well migration plates are designed as a single insert
containing all filter wells in one piece. Each filter insert (A) has a UV opaque membrane
(B) with 8.0 pm pores. Inserts fit into a well (C) of a 24 or 96 well reservoir plate. The
underside of the filters were left uncoated, or coated with 20 pg/ml bovine plasma
fibronectin, type IV collagen, or laminin-1 (Gibco BRL, Grand Island, NY) in 0.1 M
acetic acid, and allowed to evaporate. The filter insert was submersed in wells of feeder
plate containing DME with IX GPS and 1 mM sodium pyruvate or DME supplemented
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FIG. 1. Individual filter insert and feeder well of a 24 or 96 well migration plate. Test
cells are loaded into filter insert (A), and allowed to migrate across a fluorescence opaque
filter (B) towards media in feeder well (C). Cells are subsequent^ labeled with
fluorescent indicators of cell migration and cell death. Emitted fluorescence of m^rated
cells is measured fiom underneath the filter (D). Emitted fluorescence o f non-viable cells
is measured from above the filter (£).
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with IX GPS and 10%FCS. 100,000 cells suspended in DME with IX GPS and 1 mM
sodium pyruvate were added to the inside of each filter well (80pl and lOOpl for the 96
and 24 well plates, respectively). For drug studies, drugs were added to cell suspension
immediately before loading cells into migration plate. 30 minutes before the end o f the
migration assay, calcein-AM was added to the feeder wells at a final concentration of
5pM. Filters and wells were washed twice in PBS to remove excess dye. Fluorescence of
calcein-AM labeled cells was measured firom the bottom of the plate (D) in a Tecan
SpectraFluor plate reader (Research Triangle Park, NC) with 485 nm excitation and 530
run emission filters. As an indicator of cell death, propidium iodide fluorescence was
measured fix)m the top of the filter insert (E).
Quantification o f Cell Death
Cells grown in 96 well plates were incubated for four hours in 200 pi per well of the
appropriate media supplemented with 1.25mg/ml MTT (3-[4,5-Dimethylthiazol-2-yl]2,5-diphenyltetrazolium bromide; Thiazolyl blue). To release reduced MTT from viable
cells, 150 pi o f media was replaced with acidic isopropanol (99.7% isopropanol, 0.3%
12. IN HCl) and wells were incubated overnight at room temperature. Absorbance was
measured at 570nm vs. 630nm reference using a Tecan SpectraFluor. Quantification of
cell death by fluorescence was performed as previously described (21). Briefly, 1.2 mM
propidium iodide was added to media of test wells or filters to reach a final concentration
o f 30pM and incubated for 30 minutes at 37®C. As a positive control, cells were lysed in
1% Triton X-100 (Sigma, St. Louis, MO) detergent during incubation with propidium
iodide. Fluorescence of incorporated dye was measured at 560nm excitation, and 645nm
emission wavelengths using a Tecan SpectraFluor.
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Statistical Analysis
Anova/T-test was perfonned on data from indicated figures using a 95% confidence
interval. All experiments were conducted at least three times with four to sixteen
replicates per condition.

Results
Fluorescence o f Labeled Cells Correlates Linearly with Cell Number
In order to quantify migrated cells automatically, cells were labeled with the live cell
fluorescent indicator calcein-AM, and a standard curve comparing relative fluorescence
units (RFU) vs. cell number was obtained (Fig. 2). Specific numbers of pre-labeled MCFlOA cells were plated in a 96 well tissue culture plate and RFU measurements of these
cells correlated linearly with cell number (Fig. 2A). Because the plate reader parameters
and dimensions of the plates are slightly different in a migration assay, we confirmed this
correlation of cell number with RFU on migratory cells on the bottom of the migration
filter. MCF-lOA cells were allowed to migrate towards serum through transparent
transwell filters. Non-migratory cells were removed from the upper wells, and migratory
cells measured by both calcein-AM labeling and visual counting of cells in five
representative fields o f each filter (Fig. 2B). Similar results were observed with MDAMB-435 cells (data not shown).
A UV Opaque Membrane Allows fo r Detection o f Migratory vs. Non-Migratory Cells
The use of a fluorescence opaque membrane simplifies migration assays and allows
separate detection of fluorescently labeled cells on either side of the membrane. The
absorption spectrum o f the membrane used in our assay is effective at blocking a UV
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FIG. 2. Calcein-AM fluorescence correlates linearly with cell number. (A) The indicated
number of prelabeled MCF-lOA cells was plated in a 96-well plate and fluorescence
intensity was measured. (B) Chemotactic migration o f 30,000-120,000 MCF-lOA cells
was measured in a transwell migration fiher by calcein-AM fluorescence (y axis) and
subsequently the cells were fixed and stained, and representative fields counted (x axis).
Error is represented as the standard deviation o f 8 wells.
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signal through the membrane if either the emission or excitation wavelength of the
fluorescent indicator used falls within the absorption band (data not shown and ref. 22).
These filters effectively block the fluorescence (>95%) firom the opposite side o f the
membrane of either of the dyes used in our assays (data not shown and ref. 22). This
membrane simplifies endpoint analysis by eliminating the need to remove non-migratory
cells before quantifying migratory cells. MCF-lOA and MDA-MB-435 cells were
allowed to migrate through fluorescence opaque filters of 96 or 24 well filter plates
towards serum (chemotaxis) or the indicated matrices (haptotaxis), and migration was
quantified by calcein-AM labeling (Fig. 3). The data in figure 3 demonstrate that both
cell lines migrated more towards fibronectin than other matrices. For this reason,
fibronectin was chosen as the haptotactic stimulus for all drug studies. Note that
fluorescence values for each cell line cannot be directly compared to each other as
different cell lines exhibit different labeling efficiencies. For example, MCF-lOA cells
emit a fluorescence that can be as much as 40% brighter than that emitted by similarly
labeled MDA-MB-435 cells (data not shown).
Cytotoxic Properties o f Drugs can be discernedfrom Anti-Migratory properties with the
Fluorescent Indicator Propidium Iodide
Because a cytotoxic compound will halt migration by killing cells, the cytotoxic
effects of tested compounds must be evaluated in screens for anti-migratory drugs. To
this end, we incorporated a fluorescence based cytotoxicity assay that was performed in
the upper well of the migration plate immediately following the migration assay. This
protocol was adapted firom Nieminen et al. (21). The DNA intercalator propidium iodide
is a cell impermeant dye whose fluorescence is increased 10 fold upon binding DNA
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FIG 3. MCF- lOA and MDA-MB-435 cells each migrate with different strength towards
serum and bound matrices. 120,000 cells were allowed to migrate towards the indicated
stimulus in 24 and 96 well filter plates with fluorescence opaque filters. Migrated cells
were quantified ly calcein-AM fluorescence. Error is represented as standard deviation o f
16 wells.
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(23). The dye is incorporated into membrane compromised, non-viable ceils, and is
excluded from viable cells. Propidium iodide was added to the upper well o f the
migration plate thirty minutes before the end of the migration assay. Propidium iodide
fluorescence measurements inversely correlated with results obtained with the 3-[4,5Dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide; Thiazolyl blue (MTT) cell
viability assay in experiments where cells were exposed to increasing concentrations of
sodium azide (Fig. 4). Similar results were seen when cells were exposed to tamoxifen
and sodium arsenite (data not shown). Therefore, propidium iodide uptake can be used as
a quick and reliable indicator o f cell death.
The Potential Anti-Metastases Drug CAI and the Common Anti-Breast Cancer Drug
Tamoxifen Inhibited Breast Cell Migration at Non-Cytotoxic Concentrations
To demonstrate the effectiveness of our assay for measuring anti-migratory and
cytotoxic properties of drugs, we compared CAI and tamoxifen on a non-tumorigenic and
a highly metastatic breast cancer cell line. Both tamoxifen and CAI inhibited migration in
a dose-dependent manner at sub lethal concentrations, and CAI was more effective than
tamoxifen at halting migration in all cases (Fig. 5). Haptotactic migration on fibronectin
was more sensitive to drug effects than chemotactic migration towards serum of both cell
lines (Fig. 5, A-D). MCF-lOA cells exposed to 10 pM CAI demonstrated a 45%
inhibition of haptotactic migration (Fig. 5C). At 20pM CAI, haptotaxis of these cells was
completely abolished, and chemotaxis was inhibited 33%. In contrast, lOpM tamoxifen
inhibited MCF-lOA haptotaxis by only 17%. At 20 pM, tamoxifen abolished haptotactic
migration of MCF-lOA cells and inhibited chemotaxis by 27% (Fig. 5A). MDA-MB-435
cells exposed to 10 pM CAI demonstrated 32% inhibition of haptotaxis and 7%
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inhibition of chemotaxis. At 20 pM, CAI abolished haptotaxis and inhibited chemotaxis
by 42% (Fig. 5D). MDA-MB-435 cells exposed to tamoxifen, however, demonstrated
non-significant inhibition of chemotaxis and haptotaxis at 10 fiM, and, at 20 pM, only
51% inhibition o f haptotaxis and 9% inhibition of chemotaxis (Fig. 5B). In addition,
MCF-lOA cell viability was more sensitive to CAI than MDA-MB-435 cells, as
evidenced by increased propidium iodide fluorescence (Fig. 5C,D). Vehicle alone
(DMSO, 95% ethanol) did not significantly affect migration in any case (data not shown).

Discussion
Several screening strategies currently exist for the identification of cytotoxic
compounds, such as the National Cancer Institute's in vitro anticancer drug discovery
screen (24). While unregulated cell migration is a nefarious aspect of cancer progression
and other pathological processes such as arthritic inflammation, no high-throughput
methods exist to identify inhibitors of cell migration. This is largely because conventional
migration assays require excessive manipulation that reduces throughput and thus
precludes them fi*om being used in large-scale screens for anti-migration compounds. In
addition to the transfilter, modified Boyden chamber assay presented here, other methods
for measuring cell ntigration include two dimensional assays that measure random, nondirectional movement on a flat surface and three dimensional migration/invasion assays,
where cells are seeded into, or allowed to invade a gelatinous matrix. We chose to use the
transfilter migration assay based on the modified Boyden chamber for ease of use and
simple determination of migrated vs. non-migrated cells.
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In traditional Boyden chamber filter migration and invasion assays, the migratory or
invasive cells are fixed, stained, and counted visually under a microscope. In this
procedure, only representative fields are chosen and counted, a process that introduces
operator bias. In order to discern migratory from non-migratory cells in these assays,
non-migratory cells must be physically removed from the upper surface of the membrane.
Aside from adding extra manipulation into the assay, the assessment may only be
performed once, and it is difficult to assay viability of the removed cells. Cell
quantification by fluorescence detection accounts for the fluorescence contribution of
every cell, thus omitting operator variability. Other protocols for simplifying the
quantification of migrated cells in a modified Boyden chamber apparatus use markers of
cell number that are detected after the migrated cells have been lysed. These markers
include radioactivity o f cell lysate from ^'Cr-labeled cells (25), enzyme activity (26), and
absorption of a cellular dye (27). Martin et al. (28) have introduced a protocol for
measuring neutrophil migration that also uses calcien-AM for the r ^ id and sensitive
detection of migratory cells. While their protocol takes advantage of a high-throughput
format (Neuro Probe, Gaithersburg, MD), this plate does not have a fluorescence opaque
filter, thus requiring that non-migratory cells are scraped from the filter before
quantification. Ours is the only protocol designed for the detection of cancer cell
migration that incorporates both cell death and migration measurements of the same test
cell population in the same assay.
Typical plates designed for transfilter migration assays are capable of handling only
12-24 samples each. Improvements to this design presented in this protocol have made
the Boyden chamber easier and faster to use. These improvements include increasing the
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numbers of test chambers per plate, decreasing the size of the test chambers, and
constructing all of the test chambers as one piece, so that all samples per plate can be
handled simultaneously.
The complexity of signaling cascades regulating migration indicates that many
different strategies can be exploited to disturb the stimulation of migration. The ability to
migrate through the tissues of the body is a complicated process involving tissue
remodeling, directed movement, and arrest at sites of action (1). Aside from being an
integral aspect of cancer metastasis, cell migration also plays an important role in normal
cellular processes such as embryonic development, wound healing, angiogenesis, and the
immune response. Each step is tightly regulated in normal tissues, and involves the
coordination of signals from extracellular matrix receptors, primarily integrins, and
growth factor receptors (10,29). The controls regulating cell movement, while
incompletely understood, are diverse, and vary among cell type. Compounds identified
by this assay could affect any one o f those processes, and identifying the mechanisms of
action of those compounds could help clarify how cell migration is accomplished.
In this report, we demonstrate that tamoxifen, an anti-estrogen that competes with
estrogen for binding the estrogen receptor (HR) (30), inhibits migration, and causes cell
death of estrogen receptor negative (MDA-MB-435) and estrogen receptor positive
(MCF-lOA) cells. This effect is not surprising since tamoxifen is shown to have an
alternate mechanism for affecting anti-proliferation and cytotoxicity, besides binding the
estrogen receptor. In fact, ER negative cancer patients can respond to tamoxifen while
ER positive patients can be insensitive (31). ER negative breast cells including MDAMB-435 cells have also been shown to respond to tamoxifen in vitro (31, 32).
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The use o f a fluorescence blocking membrane suggests the possibility of measuring
cell migration over time, as opposed to strictly endpoint analysis. We attempted to
measure the decrease in fluorescence from the top of the filter plate and extrapolate those
RFU measurements to cell number by comparison to a standard distribution of cells
contained in wells of the same plate. To achieve this, the cells would have to be pre
labeled with a bright, stable dye that did not influence cell migration patterns. We
assessed four classes of live cell fluorescent dyes for these properties, calcein-AM, SPDiOCig(3), CellTracker Blue, and carboxyiate modified fluorescent polystyrene
microspheres (all purchased from Molecular Probes, Eugene, OR). Calcein-AM is a low
affinity calcium chelator (23), and inhibits migration of our cell lines, probably by
interfering with calcium signaling required for migration (data not shown). These data are
not surprising, as release of calciiun from intracellular stores and opening of calcium
chaimels in the plasma membrane is a consequence of integrin binding and requisite for
migration under certain conditions (11,33,34). SP-DiOCig(3) is a lipophilic
carbocyanine membrane probe that is highly fluorescent when incorporated into cell
membranes (23). While adhesion and migration are dependent upon membrane integrity,
we found that SP-DiOC|g(3) did not influence migration and only subtly influenced
adhesion in our cell lines (data not shown). While this dye showed promise, it exhibited
less intense emission than calcein-AM and thus produced less sensitive results. In
addition, while the fluorescence of this dye persisted throughout the migration assay, we
found fluctuations in emission that interfered with results and were not readily explained.
These fluctuations could be due to turnover of the cell membrane during the course of the
assay or inherent limitations of the plate reader. CellTracker Blue is a cell-permeant thiol
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reactive probe thought to produce fluorescent-glutathione adducts (23). This dye lacked
the emission intensity required for these studies (data not shown). Carboxyiate modified
fluorescent polystyrene microspheres offer another option for labeling migratory cells in
a kinetic assay. These microspheres were spontaneously endocytosed and retained in the
cytoplasm in our cell lines and do not interfere with invasion in vivo (35). In our assays,
however, carboxyiate rrticrosphere labeling demonstrated poor reliability and sensitivity,
perhaps by being processed and exocytosed from the cells before completion of the
migration assay (data not shown). While these dyes are very effective in applications
such as fluorescence microscopy where individual cells are visualized, they were not
effective for quantifying large cell populations in kinetic migration assays.
In summary, we introduce a fluorescence based, high throughput assay for screening
potential anti-migratory compounds. With the use of two fluorescent indicators, this
assay is designed to discern between cytotoxic and non-cytotoxic mechanisms of action
o f migration inhibiting compoimds. Using this assay, we demonstrated that both the
experimental anti-cancer compound CAI and the common breast cancer treatment
tamoxifen inhibited cell migration at sub-cytotoxic concentrations. While MDA-MB-435
cells showed some resistance to cell death induced by high concentrations of CAI, CAI
was more effective than tamoxifen at halting migration o f both cells lines.
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CHAPTERS

HEAT SHOCK PROTEIN 27 PLAYS TWO DISTINCT ROLES IN CONTROLLING
HUMAN BREAST CANCER CELL MIGRATION ON LAMININ-5

This chapter has been published in Molecular Cell Biology Research
Communications and is presented in the style of that journal. The complete citation is:
Rust, W., Kingsley, K.,Petnicki, T., Padmanabhan, S., Carper, S.W., Plopper, G.E. 1999.
Heat Shock Protein 27 Plays Two Distinct Roles in Controlling Human Breast Cancer
Cell Migration on Laminin-5. Molecular Cell Biology Research Communications 1,
pp196-202.

Abstract
It has recently been reported that phosphorylation of the small heat shock protein 27
(hsp27) enhances p38 MAP kinase dependent migration o f bovine and human vascular
endothelial cells. We have examined the role of hsp27 in controlling the constitutive
migration of human breast cancer cells on the extra-cellular matrix molecule laminin-5.
In a haptotaxis assay, anisomycin- or heat shock-induced phosphorylation of hsp27
enhances migration of MDA-MB-231 breast cancer cells constitutively over-expressing
hsp27. Under these conditions, hsp27 redistributes to the nucleus. Unphosphorylated
hsp27, which remains in the cytosol, induces resistance to a subset of drugs that inhibit
haptotactic migration of these cells. We conclude that hsp27 plays two distinct roles in
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controlling migration of breast cancer cells; phosphoiylated hsp27 enhances migration,
while unphosphorylated hsp27 can sustain migration in the presence o f inhibitory drugs.

Introduction
Heat shock protein 27 (hsp27) is a member of the heat shock family of proteins,
which confer resistance to a variety of cellular stresses (reviewed in 1,2). Hsp27 over
expression confers resistance to acute heat shock and some anti-cancer drugs (1,3).
Hsp27 function is thought to be controlled by its phosphorylation state and intracellular
localization, however, the exact mechanism remains unclear.
Following heat shock, hsp27 is phosphorylated and redistributes to the nucleus (1).
This phosphorylation is mediated by mitogen activated protein kinase activated protein
kinase 2/3, (MAPKAP K2/3) (1), which in turn is activated by upstream kinases ERK
1/2, JNK/SAPK, and p38 MAPK (2-4). Phosphorylation-deficient mutants do not confer
heat shock resistance, suggesting that phosphorylation is critical to its ability to protect
cells from heat (3).
In vitro, hsp27 inhibits actin polymerization (2,3). In vivo, hsp27 complexes are
sometimes associated with actin filaments in motile cell protrusions such as lamellipodia,
filopodia, and membrane ruffles (5), suggesting it may play a role in controlling cell
motility or cytokinesis, though its exact role in these activities is unclear (6,7).
Extracellular matrix (ECM) proteins play a critical role in controlling numerous
functions in virtually all cells, including migration (8,9). The ECM protein laminin-5 is
abundantly expressed in the basal lamina of most epithelial tissues, where it promotes
growth, differentiation, and migration of epithelial cells (10-12). In the breast, laminin-5
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is the preferred adhesive substrate for nonnal breast epithelial cells and mediates
constitutive migration o f breast cancer cells (9). The relationship between hsp27 over
expression and laminin-5 mediated migration in breast cells has thus far been unexplored.
In the present study, we show that hsp27 over-expression alone does not affect
constitutive migration of MDA-MB-231 human breast cancer cells towards laminin-5.
However, phosphorylation of hsp27 by heat shock or MAPK activation enhances this
migration over control cells, concomitant with its re-localization to the nucleus. In
addition, unphosphorylated hsp27 confers resistance to drugs that inhibit cell migration,
and is localized to the cytosol. From these results, we conclude that hsp27 modulates
migration on laminin-5 by two distinct mechanisms, that can be distinguished by hsp27
phosphorylation state; phosphorylated hsp27 enhances migration, while
unphosphorylated hsp27 offers protection against migration inhibitors. These two distinct
functions may reflect the dual role of hsp27 as an actin polymerization modulator and
molecular chaperone, respectively.

Materials and Methods
Cells
MDA-MB-231 cells were maintained as previously described (9). DB46 cell line was
made by transfecting MDA-MB-231 cells with an hsp27 constitutive expression vector
(p(327), constructed by cloning the human full length hsp27 cDNA (13) fragment into the
pHpAPr-1 neo (14) under the control of the p actin promoter as previously described
(15). Control cell line DC4 was made by transfecting cells with the same plasmid lacking
the hsp27 cDNA sequence.
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Materials
SQ22536, KT5823, H89, Bisindolylmaleimide, Genistein, and Anisomycin were
purchased from Caibiochem (San Diego, CA). PD98059 was purchased from New
England Biolabs, (Beverly, MA); and pertussis toxin was purchased from List Biological
Laboratories, (Campbell, CA). Purified laminin-5 was generously provided by Desmos,
Inc. (San Diego, CA).
Immunoblotting
Cells were scraped and lysed in RIPA lysis buffer, and lysates subjected to western
blot as previously described (16). In this instance, primary antibodies were anti-hsp-27
monoclonal antibody (1:1000 dilution), Stressgen, (Victoria BC, Canada) or antiphospho-p44/42 MAP kinase (Thr202/Tyr204) monoclonal antibody (1:2500 dilution).
New England BioLabs, (Beverly, MA), and alkaline phosphatase conjugated anti-mouse
monoclonal antibody was used as the secondary antibody.
Quantification o f Apoptosis
Apoptosis was quantified using an ELISA assay kit (Boehringer Mannheim,
Indianapolis, IN). Briefly, DC4 and DB46 cells were treated with indicated
concentrations of sodium butyrate for 2 0 hours, then solubilized according to
manufacturers protocol. ELISA wells were coated with anti-histone antibody, then loaded
with cytoplasmic extracts, and finally, incubated with anti-DNA secondary antibody
conjugated with peroxidase. Absorbance of peroxidase substrate was measured at 405nm
using a Microplate autoreader (Dynatech MR5000).
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Heat Shock Survival
Survival after exposure to 45°C for various time intervals was determined by colony
forming assay as previously described (17). Briefly, cells were heat shocked at 45®C,
then allowed to grow for 9-12 days. Colonies (>50 cells) were stained with crystal violet
and counted. Percent survival is expressed relative to control, unshocked cells.
Transwell Haptotactic Migration Assay
Cell migration was determined as previously described (9) except that cells were
stained with 5 pM calcein AM, Molecular Probes, (Eugene, OR) added directly to the
migration wells 30 minutes prior to measuring migration. To quantitate migration, the top
side of each filter was wiped with a cotton tipped applicator to remove cells that had not
migrated through the filter, and fluorescence of the incorporated dye was measured from
the filter with a fluorescence plate reader. Relative fluorescence values for each
experimental condition are expressed relative to control, untreated samples.
Phosphorylation Assay
Cells were pre-incubated with 100 pCi/ml ^^P-orthophosphate, NEN, (Boston, MA),
in 90% phosphate-fi’ee medium for four hours, then subjected to either heat or drug
treatment for 30 minutes. Cells were lysed in RIPA, and 15 pg of cell lysates was
immunoprecipitated with anti-hsp27 antibody and protein A/G agarose, Santa Cruz
Biotechnology, (Santa Cruz CA). Immunoprecipitates were separated by SDS-PAGE
(12% acrylamide), and the dried gel was exposed to film. MAP kinase phosphorylation
was determined by immunoblotting with monoclonal antibody specific for
phosphorylated MAP kinase.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

54
Miscellaneous
Cell adhesion, hnmunoprecipiation, and indirect immunofluorescence assays were
performed as previously described (16), using anti-hsp-27 monoclonal antibody and antiphospho-p44/42 MAP kinase (Thr202/Tyr204) monoclonal antibody (New England
BioLabs, Beverly, MA) as primary antibodies where indicated. For affinity captured
laminin-5 assays, untreated wells were coated with anti laminin-5 monoclonal antibody
TR-1 (20ug.ml) in lOOmM carbonate buffer (pH 9.3) for one hour at room temperature.
After washing and blocking with blotto, wells were incubated for 1 hour at room
temperature with 804G cell conditioned medium, thereby allowing for "capture" of
soluble laminin-5. Wells were then washed twice with PBST.

Results
The human breast cell line DB46 stably over-expresses hsp27
To examine the effect of hsp27 over-expression on the behavior of human breast
cancer cells, we stably transfected clones of MDA-MB-231 cells with the pP27 plasmid
containing full length human hsp27 cDNA under the control of the p-actin promoter
(15). Overexpression of hsp27 in transfected clones was confirmed by western blot
(Fig.la), and function of hsp27 in these cells was determined by resistance to sodium
butyrate-induced apoptosis and heat shock (Fig lb,c). We found that DB46 cells
expressed 2-3 fold more hsp27 and exhibited increased (10- to 100-fold greater) survival
when compared to control DC4 cells. From these results we conclude that DB46 cells
constitutively over-express functional hsp27.
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FIG 1. DB46 cells overexpress hsp27. (A) Western blet for hsp27 in resting (37X) and
heat shocked (45*’C) DB46 cells transfected with hsp27. As a control, parallel analysis
was performed on lysates 6 0 m DC4 cells transfected with a control plasmid. Note that at
both 37*’C and 45*C, DB46 cells contain approximately two- to three-fold more hsp27
than control cells. (B) Dose response analysis o f sodium butyrate-induced apoptosis.
Note that DB46 cells exhibit four-fold less ^wptosis as measured by ELISA than control
cells in response to 10 mM sodium butyrate. (C) Dose response anafysis o f % survival o f
cell colonies following heat shock at 45*C.
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Hsp27 over-expression does not alter binding o f DB46 cells to laminin-5
Because laminin-5 plays a significant role in controlling breast cell growth,
migration, and difieientiation (8,9), we compared adhesion of DB46 and DC4 cells to
laminin-5 using 30 minute cell adhesion assays. We fotmd no difference between cell
lines in adhesion to purified laminin-5 (Fig. 2). Laminin-5 was one of the most preferred
adhesive substrates compared to additional ECM proteins (Iaminin-1, collagen IV,
fibronectin).
Phosphorylation o f Hsp27 by MAP kinase enhances migration o f DB46 cells on
laminin-5
We determined the impact of hsp27 over-expression on haptotactic migration towards
laminin-5 using in vitro Transwell assays. DB46 cells retained the constitutive migration
of parental MDA-MB-231 cells on laminin-5, as did control DC4 cells (Fig. 3).
Therefore, hsp27 overexpression alone does not significantly affect migration of DB46
cells. Under these conditions, hsp27 was weakly phosphorylated in both DB46 and DC4
cells. However, stimulation of hsp27 by exposure to 4I°C, or via activation o f MAP
kinase with 10 ng/ml anisomycin, led to a significant (29-53%) enhancement of
migration in DB46 cells (Fig.3a). Under these conditions, both ERK 1/2 and hsp27 were
phosphorylated, as determined by western blot with anti-phospho-ERK 1/2 antibody (Fig.
3b) and immunoprécipitation of hsp27 from ^^P0 4 radiolabeled cells (Fig. 3c). Addition
of the MEKl (upstream activator of ERK 1/2) inhibitor PD98059 did not significantly
inhibit migration under normal conditions. These results indicate that hsp27
phosphorylation by beat or MAP kinase activation enhances migration. While hsp27
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FIG 2. hsp27 overe?q)ressioii does not alter binding o f DB46 cells to laminin-5. DB46,
DC4, and parental MDA-MB-231 cells were plated on the indicated ECM proteins for 30
minutes, gentfy washed to remove imboimd cells, then fixed, stained, and quantitated as
described in Materials and Methods. Ln-1= Mouse Iaminin-1, Ln-5 =laminin-5,
TRl=mouse monoclonal anti-laminin-5 antibody, 804G=conditioned medium fi*om 804G
cells containing laminin-5. Laminin-5 was captured by affinity method using TRl
antibody as described in Materials and Methods. Data are presented as statistical mean
+/- standard deviation ( i^ l 6 ).
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(C) hnmunoprecipiation a n a ^ is of phosphorylated hsp27.
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phosphorylation correlated with enhanced migration in DB46 cells, the degree of
migration enhancement varied with the relative phosphorylation o f MAP kinase.
DB46 cells resist a subset o f migration inhibiting drugs
Hsp27 over-expression confers resistance to drugs that induce apoptosis and inhibit
growth, possibly by modulating intracellular signaling pathways. To test the hypothesis
that hsp27 influences laminin-5-associated migration signaling pathways, we repeated
our cell migration assays in the presence of several drugs that inhibited intracellular
signaling molecules and reduced migration of parental cells.
We found that DB46 cells were less sensitive to a subset of these drugs than the DC4
control cells. Specifically, these cells were less sensitive to the migration inhibiting
effects of pertussis toxin (Ipg/ml), (74% vs. 51% of control migration), which inhibits
activation of the heterotrimeric G protein subunit Ga,; and completely insensitive to a
sublethal dose of a specific inhibitor of PKG (KT5823, lOpg/ml), (96% vs. 43% of
control migration) (Fig. 4). In contrast DB46 cells were equally sensitive to inhibitors of
adenylate cyclase (SQ22536,50pM), protein kinase A (H89, lOpM), protein kinase C
(bisindolylmaleimide, lOpM) and protein tyrosine kinases (genistein, 50pM) (Figure 4).
Thus, hsp27 protection under these conditions is not broadly applied but specific to
certain signaling pathways involving at least PKG and Gai.
The hsp27 that confers resistance to migration inhibiting drugs is unphosphorylated
Because hsp27-enhanced migration of DB46 cells is phosphorylation-dependent, we
determined the phosphorylation state of hsp27 under conditions where it conferred
resistance to migration inhibiting drugs. Identical concentrations o f drugs used to inhibit
migration were administered to ^^P0 4 -labeled cells for 30 minutes, and hsp27
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phosphorylation was determined by immunoprécipitation and autoradiography. Except
for modest phosphorylation by bisindolylmaleimide, no drug treatment induced hsp27
phosphorylation over background levels (Fig. 5). These results demonstrate that hsp27
plays two discrete roles in controlling migration in DB46 cells: unphosphorylated hsp27
protects against the migration-inhibiting effects of pertussis toxin and KT5823, while
only phosphorylated hsp27 enhances MAP kinase-dependent migration. Percent
migration relative to control (37°C, no drugs) is indicated above band for each treatment.
Enhancement o f migration by phosphorylated hsp27 correlates with its relocalization to
the nucleus
Phosphorylation o f hsp27 can affect its intracellular localization (18). Because we
observed that hsp27 phosphorylation distinguished between its migration-enhancing or
drug resisting effects, we determined its subcellular localization under both conditions.
Indirect immunofluorescence microscopy revealed that, in the absence of heat shock or
drug treatments, hsp27 was distributed throughout the cytosol with a slight concentration
in the perinuclear region (Fig. 6 , panel B). Upon heat stimulation or treatment with
anisomycin, hsp27 relocated to the nucleus within 45 minutes (Fig. 6 , panels F,H). In
contrast, hsp27 did not relocalize in cells treated with pertussis toxin (Fig. 6 , panel D).
From the above data, we conclude that hsp27 plays two distinct roles in controlling
migration of DB46 cells on laminin-5: when phosphorylated, hsp27 concentrates in the
nucleus and enhances constitutive migration, while unphosphorylated hsp27 remains
distributed throughout the cytosol and offers resistance to a subset o f signaling inhibitors
that reduce constitutive migration.
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Discussion
Our data present three lines of evidence that hsp27 acts in two distinct roles to affect
cell migration. First, activation of MAP kinase cascades by anisomycin leads to
phosphorylation of hsp27 and enhanced migration. While overexpression of hsp27 can
enhance cell migration in a phosphorylation dependent manner (19), the upstream
signaling m echanism s responsible for mediating this effect are not well defined. In

endothelial cells, p38 and SAPK2, but not ERK 1/2, mediate hsp27-dependent
modulation of the actin cytoskeleton and chemotactic migration (4,20,21). However, the
MAP kinase ERK 1/2 is implicated in ECM mediated events and may be involved in
haptotactic migration on laminin-5 (22). Inhibition of ERK 1/2 by PD980S9 did not
inhibit haptotactic migration on laminin-5, though it's phosphorylation by anisomycin did
correlate with enhanced migration. This result does not rule out the involvement of p38
and SAPK, both of which are activated by anisomycin (23).
Second, unphosphorylated hsp27 offers protection against inhibitors of specific
intracellular signaling molecules in our cells. Hsp27 selectively protects against cytotoxic
compounds, some of which stimulate intracellular signaling cascades (24, 25), perhaps by
acting as a molecular chaperone (24); this protection is not always phosphorylation
dependent (26). In our cells, hsp27 confers resistance to the repression of migration by
inhibitors of PKG and adenylate cyclase, but not inhibitors of PKA and PKC. These
results raise the possibility that hsp27 may function as a molecular chaperone or signaling
molecule to maintain activity of a subset of signaling pathways required for constitutive
migration of malignant tumor cells.
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Third, hsp27 redistributes to the nucleus and sites of actin polymerization when
phosphorylated, and remains cytosolic when unphosphorylated. This differential
distribution correlates with the two distinct functions we observe in our cells,
enhancement of migration, and protection against signaling inhibitors. Others have
reported similar changes in distribution of hsp27 in response to serum stimulation (2,18),
although re-localization in response to heat shock may be independent of hsp27
phosphorylation (5).
In summary, the most significant finding of this study is that hsp27 affects migration
of breast cancer cells by two distinct mechanisms. Further, these mechanisms can be
distinguished on the basis of hsp27 phosphorylation state and intracellular localization.
Because hsp27 is thought to act as a molecular chaperone, our data support a model
whereby unphosphorylated hsp27 sequesters damaged signaling molecules, thereby
conferring resistance to drugs that otherwise inhibit haptotactic migration o f breast cancer
cells. Because phosphorylated hsp27 functions as an actin capping protein in vitro (4),
this may explain why it enhances constitutive migration of breast cancer cells; In our
model, phosphorylation of hsp27, coupled with a haptotactic migration stimulus (e.g.,
binding to ECM proteins such as laminin-5), may enhance actin filament assembly within
the leading edge of migrating cells.
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CHAPTER 4

ANTIBODY INDUCED ACTIVATION OF pi INTEGRIN RECEPTORS
STIMULATES cAMP-DEPENDENT MIGRATION OF
BREAST CELLS ON LAMININ-5

This chapter has been published in Molecular Cell Biology Research
Communications and is presented in the style of that journal. The complete citation is:
Plopper, G.E., Huff, J.L., Rust, W.L., Schwartz, M.A., Quaranta, V. 2000. Antibody
induced activation of pi integrin receptors stimulates cAMP-dependent migration of
breast cells on laminin-5. Molecular Cell Biology Research Communications 4, ppl29135.

Abstract
The pi integrin-stimulating antibody TS2/16 induces cAMP-dependent migration of
MCF-lOA breast cells on the extracellular matrix protein laminin-5. TS2/16 stimulates a
rise in intracellular cAMP within 20 minutes after plating. Pertussis toxin, which inhibits
both antibody-induced migration and cAMP accumulation, targets the Gai3 subunit of
heterotrimeric G proteins in these cells, suggesting that Gai3 may link integrin activation
and migration via a cAMP signaling pathway.
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Introductioii
Laminins are a diverse group of heterotrimeric extracellular matrix proteins that
constitute a major component of the basement membrane o f epithelial tissues. The
laminin-5 isoform, consisting of the o3, p3 and y2 subunits, is abundantly expressed in
the basement membrane of breast tissue [ 1 ] where it plays a role in mammary branching
morphogenesis, and adhesion and migration of breast epithelial cells [2 ].
Evidence from both in vitro and in vivo studies support a frmctional role for laminin-5
in cell migration of both normal and malignant breast epithelial cells. Our laboratory has
previously shown that in vitro, laminin-5 is the preferred adhesive substrate for breast
epithelial cells [1]. In haptotactic migration assays, non-tumorigenic breast cell lines fail
to migrate significantly on laminin-5, whereas laminin-5 supports migration of highly
malignant breast cell lines. In vivo, laminin-5 expression is enhanced in invading regions
of metastatic breast tumors[3j. In addition, an altered conformation of laminin-5,
resulting from proteolytic cleav%e of the y2 chain by matrix metalloprotease 2 , is found
at sites of tissue invasion, and this cleavage stimulates migration of otherwise non
migrator) breast cells in vitro [4]. Laminin-5 may contribute to the progression o f
tumorigenic breast cells from the stationary to malignant phenotype by stimulating
enhanced migration o f these cells.
Cells interact with laminins primarily through integrin receptors [5]. Ligand induced
signal transduction by integrin/laminin binding regulates intracellular pH, tyrosine
phosphorylation, inositol lipid metabolism, and calcium (Ca^^ oscillations [6 ]. Signaling
molecules known to associate with integrins receptors include protein tyrosine kinases,
serine/threonine kinases, phospholipid kinases and lipases, ion channels, and members of
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the rho family of small molecular weight GTP binding proteins [6 ]. Laminin-5 is
recognized by the a S p l, a 6 pi and a6p4 integrin receptors in a number o f cell types, and
the functional consequence of these interactions depend on the integrin receptor engaged.
For example, ligation o f laminin-5 with the «6^4 integrin receptor supports branching
morphogenesis and hemidesmosome formation in breast epithelial cells [2 ], while
interaction with o3P 1 integrin supports migration of these same cells in vitro [7]. Little
information is currently available on the specific signaling pathways triggered during
these events.
While investigating the role o f the a3p 1 integrin in motility of breast epithelial cells,
we observed that haptotactic migration of the immortalized breast epithelial cell line
MCF-lOA on laminin-5 was stimulated by direct activation o f the p i integrin receptor
with the pi-activating monoclonal antibody TS2/16. Migration was dependent on
intracellular cAMP signaling, and TS2/16-promoted a rise in intracellular cAMP levels
that occurred 20 minutes after plating on laminin-5. Migration and cAMP accumulation
were inhibited by treatment of the cells with pertussis toxin, a compound that inactivates
the a subunit of the inhibitory class of heterotrimeric G proteins via ADP-ribosylation.
We show that the Gai3 isoform is a target for ribosylation by pertussis toxin in these
cells. Together these data present evidence that the pi integrin participates in the
regulation of MCF-lOA cell migration on laminin-5 through a cAMP-signaling pathway
involving Gai3. This is the first description linking integrin activation to signaling
through heterotrimeric G proteins.
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Materiab and Methods
Cells
MCF-lOA cells were maintained in DFCI medium according to Band and Sager [8 ].
MDA-MB-231 cells were cultured as described [1]. Rat 804G cells were maintained in
Dulbecco's Modified Eagle's Medium (DMEM) containing 10% fetal calf serum and IX
Glutamine Pen-Strep solution (Irving Scientific). 804G cell conditioned medium was
collected after 3 days of culturing and was clarified by centrifugation at 1500 x g.
Reagents
Mouse monoclonal antibodies against human integrin o3 (clone P1B5) and PI (Clone
P4C10) were purchased from Gibco (Gaithersburg, MD). Mouse monoclonal antibody
clone P5D2 against human pi integrin was purchased from Chemicon (Temecula, CA).
Purified rat anti-mouse pi antibody 9EG7 was purchased from Pharmingen (San Diego,
CA), and dialysed against PBS to remove sodium azide. Mouse monoclonal anti-human,
activating pi integrin antibody TS2/16 (in ascites form) was generously provided by Dr.
Martin Hemler (Dana Farber Cancer Institute, Boston, MA). Anti-rat laminin-5
monoclonal antibody TRl was produced in-this laboratory [9]. Both TS2/16 and TRl
were purified with a protein G affinity chromatography kit (Pierce, Rockland IL).
SQ22536 was purchased from Biomol (Plymouth Meeting, PA) and pertussis toxin from
List Biological Laboratories, Inc. (Campbell, CA). 8 -Bromo-cAMP, dibutryl cAMP, H89, and forskolin were purchased from Calbiochem (San Diego, CA).
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Adhesion and migration assays
Adhesion and migration assays were performed as previously described [I]. For antiintegrin antibody blocking experiments, antibodies were incubated with cells for 30
minutes before adding to assay wells, and were present throughout the assays.
cAMP determination
Cells were collected by brief trypsinization, blocked with trypsin inhibitor, washed in
DMEM, counted, resuspended at 1 x 10^ cells/ml, and incubated at 37°C in migration
mediiun/1 mM isobutylmethylxanthine (Sigma) to block phosphodiesterase activity.
After 30 minutes, anti-integrin antibodies (TS2/16 or P5D2) were added, and cells were
incubated at 37°C for an additional hour. Control cells were suspended in DMEM/1 mM
isobutylmethylxanthine alone during this time. Cells (1 x 10^/plate) were then plated on
35 mm dishes coated with affinity-captured laminin-5 [ 1] and incubated at 37°C for the
indicated times. Cells representing the 0 time point were immediately retrieved from the
dishes, collected by centrifugation, and lysed in cold cAMP extraction solution (95%
ethanol, 5% 0.1 N HCI). After 10,20,30, and 90 minutes non-adherent cells were
aspirated, plates were washed with PBS, and cAMP extraction buffer was added to the
adherent cells. The PBS washes firom each plate were centrifuged to collect loosely
adherent cells, and these were added back to the appropriate extraction. All samples were
kept on ice in cAMP extraction buffer for 2 hours, then centrifuged to pellet precipitated
protein. Protein was dissolved in 0.1 N NaOH and concentrations were determined with
the BCA microassay (Pierce). Supemantants were evaporated and cAMP measured using
a cAMP EIA kit (Perseptive Diagnostics, Inc., Cambridge MA) as directed by the
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manufacturer. cAMP amounts were normalized to total protein in each sample and
expressed as finol/pg protein.
ADP ribosylation assay
Membranes were isolated from MCF-lOA cells by lysis in ice-cold 10 mM HEPES
pH 7.5,3 mM MgCh, 2 mM EDTA containing 10 pg/ml leupeptin, 2 pg/ml aprotinin,
and 0.5 mg/ml Pefabloc SC (Boehringer Mannheim Biochemicals, Indianpolis, IN).
Cells were scraped, centrifuged to pellet nuclei, and the supernatant was collected.
Membranes were pelleted from supernatant by centrifugation at 13,000 x g for 30
minutes at 4°C; and the pellets were resuspended in lysis buffer. Protein concentrations
were determined by BCA protein assay (Pierce).
ADP-ribosylation and Immunoprécipitation:
ADP-ribosylation reactions were performed as described [10]. Final reaction
conditions were as follows: lOOpg membrane protein was suspended in 20 mM
thymidine, 1 mM ATP, 1 mM GTP, 1 mM EDTA, 20 mM HEPES, pH 7.5 with or
without 7.5 pg pertussis toxin (activated prior to experiment by incubation for 10 minutes
at 37°C in 20 mM DTT, 20 mM HEPES, pH 7.5) and 25 pCi ^^P-NAD (Specific activity
= 30 Ci/mM, New England Nuclear catalog # BLU023). Reactions proceeded for 45
minutes at 30®C and were stopped by chilling to 4°C followed by a wash with 20 mM
HEPES pH 7.5,1 mM EDTA and 1 mM DTT. For SDS-PAGE analysis, membranes
were solubilized in 50 pi Laemmli sample buffer (LSB), heated for 5 minutes at 100“C
and separated on a 12% SDS-polyacrylamide gel. ^^P-labeled proteins were detected by
autoradiography of dried gels using Kodak X-Omat AR film with intensifying screens.
For immunoprécipitations, ribosylated membrane proteins were solubilized in RIPA
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buffer containing protease inhibitors and were incubated with the following G-protein a
subunit-specific peptide antibodies: 1-20, specific for God-1; C-10, specific for God-3
(Santa Cruz Biotechnology). Immune complexes were captured by incubation with A/G
agarose (Santa Cruz Biotechnology), solubilized by boiling in LSB and analyzed by
SDS-PAGE as described.

Results and Discussion
The p i integrin activating antibody TS2/16 stimulated MCF-lOA migration on laminin-5
The non-tumorigenic breast cell MCF-lOA remains statically adherent to laminin-5
via the oc3pi integrin [1]. In haptotactic Transwell filter migration assays, these cells
demonstrated only modest migration towards laminin-5. When pre-incubated with
TS2/16, however, MCF-lOA cells increased their migration in a dose-dependent maimer
towards laminin-5 (Fig 1). TS2/16-treated cells also exhibited increased adhesion to
laminin-5 (Fig. 2). These effects are not observed with other pi targeting antibodies
(P5D2,9EG7, Fig. 1; 9EG7, Fig. 2) or with TS2/16 on other substrates (data not shown).
TS2/16 therefore stimulated a signaling pathway that, concurrent with laminin-5 binding,
led to enhanced cell migration. This pathway is dependent upon binding of the a3 p i
integrin, as pretreatment of the cells with the a3 integrin-blocking antibody P1B5
completely blocked TS2/16-stimulated migration on laminin-5 (Fig 1).
In each experiment, maximum stimulation of cell migration was observed when cells
were allowed to migrate towards a gradient of fetal calf serum. This control was included
in each migration assay to indicate the dynamic range of migration response in each
population of cells. It is likely that this chemotactic migration was stimulated by the
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FIG. l.The integrin activating antibody TS2/16 stimulates migration of MCF-lOA breast
cells on laminin-5. Indicated concentrations o f TS2/16 were added to MCF-lOA cells in a
minimal medium lacking serum or other growth foctors (MM) 15 minutes prior to plating
in laminin-5 migration assays, and migrated cells were counted 18 hours hier. As
controls, cells were plated in the presence of 10% serum, irrelevant mouse ascites (FM3
ascites), antibody purified from irrelevant ascites (FM3 pure), or non-frt dried milk
(blotto). Results are expressed as the mean of eight measurements on two filters using
300 X m^nification, +/- standard deviation.
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FIG. 2. TS2/16 antibody increases adhesion of MCF-lOA cells to laminin-S. Cells were
incubated in MM with 50 pg/ml of TS2/16 or 9EG7 antibodies for 15 minutes, then were
plated on aflSnity-captured laminin-5 for 30 minutes and adhesion quantified by
measuring absorbance of crystal violet-dyed cells at 595 nm. AfBnity capture was
accomplished by successive addition of indicated concentrations o f TRl antibody, blotto,
and 80i4G-conditioned medium containing soluble laminin-5. As a control (CTL), cells
were incubated with no antibodies prior to plating. Results «q)ressed as statistical mean
+/- standard deviation ( i^ 8 ).
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growth factors present in fetal calf serum, as serum-induced migration was inhibited by
greater than 80% Wien cells were preincubated with antibodies that block the function of
the epidermal growth factor receptor or drugs that inhibit tyrosine kinases (G.E. Plopper,
unpublished data). It is therefore likely that serum was a stronger pro-migratory stimulant
than TS2/16 because it activated several signaling pathways stimulated by soluble growth
factors, while TS2/16 targeted integrin-associated signaling pathways.
The strength o f cell adhesion to extracellular matrix ligands varies over a wide range,
and is under the control of both intracellular and extracellular cues. Work by
Lauffenburger [11] suggests that very tight or very loose cell adhesion to matrix proteins
will not support cell migration, and that migration occurs only when a medium-strength
of adhesion is achieved. Thus, varying the potency of adhesion of integrin receptors for
their ligands may be a critical step for regulating cell migration. It is possible that TS2/16
stimulated migration in these cells by changing the strength of adhesion between a S p i
integrin and laminin-5, either directly or via activation of internal signaling pathways.
Alternatively, it is plausible that TS2/16 induced a conformational change in the p I
integrin that mimicked binding to a pro-migratory form of laminin-5, such as those
created through proteolytic processing. For example, cleavage of the 72 subunit of
laminin-5 creates a conformation on which MCF-lOA cells migrate constitutively [4,12].
A pro-migratory laminin-5 can be converted to one that inhibits cell migration through
cleavage of the a3 chain [13]. In both instances it is assumed that proteolytic processing
masks or unmasks a pro-migratory domain on the intact laminin-5 trimer. This theory is
also supported by studies showing that integrin activation by TS2/16 will rescue the
growth of MCF-lOA cells inhibited by treatment with laminin-5 blocking antibodies [14].
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MCF-lOA cell migration on laminin-5 is modulated by cAMP
To define the mechanisms by which TS2/16 stimulated MCF-lOA cell migration on
laminin-5, we added inhibitors of known signaling molecules to antibody-stimulated cells
in h^totaxis migration assays. We found that SQ22536, an inhibitor of adenylate
cyclase, and H-89, an inhibitor of cAMP dependent protein kinase, completely blocked
TS2/16 stimulated migration on laminin-5 (Fig. 3). In addition, pharmacological
enhancement of cAMP levels with either forskolin or the non-hydrolygable cAMP
analogs 8 -bromo-cAMP and dibutyryl cAMP were sufficient to enhance migration of
MCF-lOA cells on laminin-5 to levels stimulated by TS2/16 (Fig. 3). Prolonged (18 hour)
exposure to pertussis toxin, a compound that inhibits the cAMP signaling pathway
mediated by the Gai class of signaling proteins, abolished migration on laminin-5 (Figure
4) and reduced cAMP levels in MCF-lOA cells over the same time course (Figure 5B).
These data established that cAMP was required for enhanced migration of MFC-lOA
cells on laminin-5.
Because adenylate cyclase activity is governed by different classes of heterotrimeric
G proteins we exposed MCF-lOA cells to pertussis toxin (an inhibitor of the Gai class)
and cholera toxin (an activator of the G as class). While both pertussis and cholera toxin
partially blocked serum stimulated migration of MCF-lOA cells (approximately 50%),
only pertussis toxin blocked TS2/16 stimulated migration on laminin-5 (Fig. 4). These
data demonstrated that the specific pathway triggered by TS2/16 and laminin-5 was
susceptible to regulation by Gai rather than Gas proteins, and again suggest that serumstimulated migration resulted firom activation of multiple signaling pathways, some of
which utilize cAMP as a second messenger.
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FIG. 3. Enhanced cAMP levels induce migration of MCF-lOA cells on laminin-5. Cells
were incubated in MM supplemented with 50 pg/ml TS2/16,50 pg/ml P1B5,250 mM
SQ22536 (SQ), 4 pM H89, 5 nM forskolin (FSK), 500 pM dibutyryl cAMP (db cAMP),
or 500 pM 8 -bromo-cAMP ( 8 -Br-cAMP) for 15 minutes prior to adding to laminin-5
migration assays. As a control, cells were plated in the presence o f serum or in MM on
filters lacking laminins (blotto). Results are expressed as in Fig. 1.
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FIG. 4. Pertussis toxin inhibits TS2/16-stimu]ated migration on laminin-5. MCF-lOA
cells were suspended for 30 minutes in MM supplemented with either 10% serum or 50
pg/ml TS2/16.100 ng/ml pertussi toxin (PT), 100 ng/ml cholera toxin (PT), were added
15 minutes prior to plating cells in laminin-5 m iration assays. As a control, cells
suspended in MM were added to filters coated with blotto alone. Results expressed as in
Fig. I.
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FIG. 5. Pertussis tcxin inhibits a cAMP peak in TS2/16-stimulated cells. MCF-lOA cells
were suspended in MM supplemented with 20 pg/ml TS2/16 or P5D2 antibodies and
plated on laminin-5 for the indicated time, then lysed and assayed for total cAMP content
by ELISA assay. As a control, cells were plated in the absence o f antibodies (CTL). The
experiments were performed (A) in the absence (-PT) or (B) presence (+PT) of 100 ng/ml
pertussis toxin. Results are normalized to total cell protein for each time point and
represent the mean of triplicate measurements for four experiments, +/- the standard error
of the means.
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Not all compounds that induced a rise in cAMP stimulated migration on laminin-5.
Cholera toxin induced a transient rise in cAMP in MCF-lOA cells (G.E. Plopper,
unpublished observations), and stimulated growth of these cells when used in small
quantities (ng/ml) in the low-serum media for these cells (DFCI medium) [8 ]. It is
generally thought that small quantities of cholera toxin stimulate growth in these cells by
activating signaling pathways used by G protein-linked chemokines (Gary Bokoch,
Department of Immunology, The Scripps Research Institute, personal communication).
Higher concentrations of cAMP (pg/ml) typically used to irreversibly activate Gas did
not stimulate haptotactic migration of MCF-lOA cells on laminin-5 (G.E. Plopper
unpublished observations), suggesting that while cholera toxin does afTect signaling in
these cells, the pathways it affects do not play a role in integrin activated migration on
laminin-5.
Chemotactic migration o f many cell types is inhibitable by cholera and pertussis
toxins [15,16]. While pertussis toxin allows for unchecked cAMP production in the short
term, prolonged pertussis toxin exposure suppressed cAMP levels in our cells, likely
because of long-term desensitization of this pathway [17]. Although O’Conner et al. [18]
reported that a6p4 expression suppressed cAMP levels in migrating breast cancer cells,
no evidence has been published linking cholera and pertussis-sensitive signaling
pathways to integrin-activated signaling.
These findings are consistent with our observation that numerous chemokines that
modulate cAMP through G as (bombesin, bradykinin, adrenaline) raised cAMP levels but
failed to stimulate migration in our cells (G.E. Plopper, unpublished data). Each of these
compounds exerts very distinct responses in breast cells, suggesting that while they share
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cAMP as a second messenger, they must generate specificity elsewhere in their signaling
pathways. The specificity necessary to modulate haptotactic migration may be generated
by localizing cAMP bursts to specific times and/or locations within a cell, by targeting
specific isoforms of adenylate cyclase, or by integrating cAMP bursts with other integrinassociated behaviors (e.g, formation of focal adhesions, generation of cellular tension,
activation of signaling pathways linked to migration in other cell types [e.g., those that
utilize rho/ras G proteins or focal adhesion kinase]) [19].
Indeed, such integration appears to take place in smooth muscle cells, which exhibit
increased migration on collagen upon activation of a cAMP signaling pathway linked to
integrin associated protein and o 2 p i integrin; this activation also stimulates the mitogen
activated protein kinase ERK, and is inhibited by pertussis toxin. [20]. In this study,
migration is stimulated upon a reduction in cAMP levels and is inhibited by analogs of
cAMP. The differences between these findings and ours may be attributed to differences
in cell type, migratory stimulus, migratory substrate, and/or integrin receptor involved:
we have observed that inhibition of o 2 pi integrin stimulates haptotactic aSpi-mediated
migration in our cells, for example (G.E. Plopper, unpublished findings).
TS2/16 stimulated a rise in intracellular cAMP via a pertussis toxin-sensitive signaling
pathway
Since pertussis toxin alters intracellular cAMP levels, and cAMP modulation was
sufficient to enhance migration in our cells, we examined the levels of cAMP in TS2/16stimulated cells plated on laminin-5. Within 20 minutes after plating, cAMP levels were
raised approximately four-fold in TS2/16 treated cells. This peak occurred within the
time firame of integrin signaling [6 ]. Enhanced cAMP accumulation was specific to
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TS2/16, and not a product o f integrin clustering, as neither cells treated with the non
activating pi antibody P5D2 nor cells plated on laminin-S without antibodies exhibited
enhanced cAMP production (Figure 5A). Pre-incubation with pertussis toxin completely
eliminated this peak but did not significantly affect basal cAMP levels (Figure SB).
Concurrent stimulation by laminin-S adhesion and TS2/16 are required, as cAMP levels
did not change in suspended cells treated with TS2/16 (G.E. Plopper, unpublished). It
appeared, therefore, that the combination of intact laminin-S and TS2/16 pretreatment
stimulated a signaling pathway involving cAMP that was specifically blocked by
pertussis toxin.
Pertussis toxin ADP-ribosylated Gcd3 in MCF-lOA cells
Pertussis toxin ADP ribosylates the Gai class of heterotrimeric G proteins. To
determine the repertoire o f Gai subunits expressed in MCF-lOAs we performed Western
blot analysis of whole cell lysates and isolated membrane fractions using polyclonal
antibodies raised against specific G protein subunits. These studies revealed that MCFlOA cells expressed G ail and Gai3, but not Gai2 (data not shown). To establish the
targets of pertussis toxin in these cells we carried out ADP-ribosylation assays in the
presence of^^P-NAD. Addition of pertussis toxin specifically induced the ribosylation of
a 43 kDa protein (Fig. 6 , lane 2). No ^^P labeled proteins are detectable without addition
of pertussis toxin (Fig. 6 , lane 1). The molecular weight of the ribosylated protein was
consistent with that of the a subunits of heterotrimeric G proteins. The identity of this
protein was determined by immunoprécipitation of the ribosylated membrane proteins
with Gail and Gai3 antibodies. Antibody CIO, which reacts primarily with Gai3,
immunoprecipitated a band of 43 kDa (Fig. 6 , lane 4). The anti-Gail antibody 1-20 failed
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FIG. 6 . Pertussis toxin specifically ADP ribosylates Goi3 in MCF-lOA cells. 100 pg of
cell membranes were incubated with 25 pCi ^^P-NAD in the presence (lanes 2-4) or
absence (lane 1) of 7.5 pg activated pertussis toxin. Pertussis toxin-treated lysates were
immunoprecipitated with anti-Gail ^-20, lane 3) or anti-Goi3 (CIO, lane 4) antibodies.
As a control, Gail was immunoprecipitated fi’om ^^P-NAD labeled lysates o f pertussis
toxin-treated MDA-MB-231 cells ( CTL, lane 5). Nfigration of molecular w ei^t
standards is shown at left.
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to precipitate any ADP ribosylated proteins in MCF-lOA ceils (Fig. 6 , lane 3), but did
precipitate a 43 kDa band from a control cell line, MDA-MB-231 (Fig 6 ., lane 5).
Therefore, pertussis toxin ribosylated Gai3, but not Gail in MCF-lOA cells.
In addition to controlling adenylate cyclase activity, Gai3 is associated with and
activates amiloride-sensitive Na^ channels [2 1 ], which are expressed in many epithelial
cells including breast. These channels are also regulated by the actin cytoskeleton [22]
and cAMP dependent protein kinase [23], suggesting that Gai3 may link integrinmediated actin polymerization, cAMP signaling, cAMP dependent protein kinase
activity, and amiloride-sensitive channel activation. Curiously, amiloride also suppresses
lung métastasés from breast tumors [24]; our data suggest that it may do so, at least in
part, by inhibiting tumor cell migration.
In conclusion, we report that the p i integrin-stimulating antibody TS2/I6 induced
migration of MCF-lOA cells on laminin-5 that was dependent upon cAMP linked
signaling. TS2/16 also stimulated a rise in intracellular cyclic AMP within 20 minutes
after plating on laminin-5. Both the enhanced migration and cAMP peak were inhibited
by pertussis toxin. Pertussis toxin targeted the Gai3 subunit of heterotrimeric G proteins
in these cells. This evidence suggests that the pi integrin participates in the control of
MCF-lOA cell migration on laminin-5 via a cAMP signal pathway regulated by Gai3.
This form of signaling, beginning with an external stimulus of the integrin receptor, is
referred to as “outside-in signaling” to differentiate it from changes in integrin function
resulting from activation of internal signaling pathways [6 ]. We propose that TS2/16
mimics the effects of proteolytic processing of laminin-5 by forcing the a 3 p i integrin
into a conformation formed by binding pro-migratory forms of laminin-5. We are
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currently examining the effect of these proteolytic modifications on intracellular
signaling activities in MCF-lOA cells. Because acquisition of a migratory phenotype is
required for malignant progression of tumorigenic breast cells, elucidating pathways
involved in enhanced migration of breast may lead to discovery of novel targets for
anticancer therapies.
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CHAPTERS

LAMININ-1 DOMAINS AS SPECIHC ACTIVATORS OF
INTEGRIN SUBTYPES

Abstract
Cells interact with laminin-1 with as many as six different integrin heterodimers.
Here I have identified integrins a 6 pl, a ip i and potentially a3 p i as laminin-1 receptors
used by MCF-lOA cells. I hypothesize that MCF-lOA cell response to laminin-1
engagement is a product of the cumulative effect of engagement of all three integrins,
stimulating at least two separate intracellular signaling cascades. To test this hypothesis, I
identified intracellular calcium flux as a downstream marker of integrin signaling
response, and demonstrated that clustering of independent integrins and different integrin
ligands stimulate unique intracellular calcium fluxes. In order to gauge the impact o f each
integrin on calcium flux, I constructed six fiagments o f laminin-1 in a baculovirus system
that likely contained integrin binding sites. Each of these were screened for the ability to
act as adhesive substrates for MCF-lOA cells. My results indicate that recombinant
domains of laminin produced by this method are not suitable integrin ligands.
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Introduction
It is tempting as a researcher to fit biological molecules into linear cascades of
specific function. It is becoming more and more evident, however, that most molecules,
especially those involved in signaling, are components of a balancing act between
intracellular events whose ultimate outcome can only be predicted by observing the net
influence of intracellular conditions within a specific time frame. For example, Ras is
recognized as a molecule that promotes cell growth via MAP kinase stimulation. In the
absence of PI-3 kinase, or NF-kB activation, Ras stimulation results in the opposite
effect, apoptosis [1]. It can therefore be postulated that specific function can not be
attached to particular molecules without taking into account other cellular conditions. In
order to gain a true understanding of integrin function, the same paradigm must be
applied.
To date, a great number of signaling cascades (kinase activation, phospholipid
metabolism, small and large G-proteins, ion current, intracellular pH) and cellular
functions (proliferation, death, migration, embryogenesis, gene transcription and protein
secretion) have been attributed to integrin activation. Since a cell will engage its matrix
ligand with only a few integrin subtypes, it is impossible to rationalize the specificity of
cellular outcomes based on linear, single-function signal cascades. The hypothesis
proposed here is that the consequence of integrin ligation is an emergent property
dependent upon the activation state of all expressed integrins. The specificity o f integrin
function is a result of cooperative balance between integrin stimulated signal cascades.
For this hypothesis to be reasonable, integrins with common substrate specificity
must be capable of stimulating different signal cascades, and must be able to
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communicate by signai cascade overlap. As an example of similar integrins sending
different signals, integrins bound to collagen type IV can either stimulate or inhibit RhoA
activity depending on the specific integrins engaged, and time course of engagement [2 ].
There are several examples in support of the integrin communication by signal cascade
overlap. Certain epithelial cells adhere strongly to laminin-5 via a 6 p i, and weakly to
laminin-1, where both aSP I and a 6 pi are engaged. Microinjection of the o3 cytodomain
disrupts a 6 pi mediated adhesion to laminin-1 , indicating that o3pi transdominantly
regulates a 6 pi activity [3]. This communication by integrin receptors is also
demonstrated in the regulation of phagocytosis and migration by macrophages [4]. In this
case, avp3 blocks a5 p i function through inhibition of CaMKII. In myocardial muscle
cells, transfection with integrin a 7 stimulates cell adhesion to laminin-1, but inhibits the
ability of native aS to bind to fibronectin [5].
In order to understand how these emergent properties of integrins are achieved, it is
necessary to be able to stimulate individual integrin subtypes alone and in combination,
across a variety of cell types. For this I chose to produce recombinant fragments of the
likely integrin binding domains of laminin-1 , and screened those for the ability to bind
one, and only one integrin subtype. Laminin-1 was chosen because it is recognized by six
integrin subtypes ( a ip i, o 2 p i, a 3 p i, a 6 p i, a7pi, a6p4) and is the most well
researched of all the laminin isoforms.
In addition to integrin specific adhesion molecules, it was necessary to identify a
marker of dynamic integrin signaling that was likely the result of cooperation between
integrin signaling cascades. Intracellular calcium (Ca^^ flux is a likely candidate as it is a
consequence of, and required for, integrin mediated adhesion and migration [ 6 and
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Figures. 1-3]. Increases in Ca^^ are seen upon cell attachment to ECM in platelets,
macrophages, neutrophils, osteoclasts, smooth muscle, epithelial, and embryonic stem
cells [7, 8 ,9]. The complex spatio-temporal aspects of Ca^^ signaling make it well suited
for the modulation o f highly coordinated processes such as migration, which require an
asymmetric regulation of cell adhesion, with formation/strengthening at the front and
disassembly/weakening at the rear [10]. Aside from being a factor which regulates
integrin affinity and avidity, several proteins which modulate F-actin assembly or
maintenance o f focal adhesions are also regulated by calcium flux. These include
calreticulin, calcineurin, calmodulin, calcium and integrin binding protein, gelsolin,
calpain, and calcium/calmodulin dependent kinase II (CamKII) [4, II, 12,13]. The
variety of mechanisms by which Ca^^ can be regulated also indicate that this is a good
molecule for analyzing dynamic regulation by the family of integrin receptors.
The mechanism by which calcium fluxes are propagated and maintained by adherent
and/or actively migrating cells is not completely understood. It is generally accepted,
however, that intracellular calcium flux results from calcium entry form both internal and
external sources. Nearly all cells carry receptor-operated and voltage-operated channels
in the plasma and ER membranes, and store operated Ca^^ charmels which are activated
by a decrease of Ca^^ in the ER [14] .Opening of Ca^^ charmels of intracellular Ca^^ stores
occurs via inositol-1,4,5-trisphophate (IP3) binding, which is produced by the action of
membrane bound phospholipase C (PLC) from the substrate phosphatidyl inositol-4,5bisphophate (PIP2). Sustained Ca^^ release is thought to be achieved by the opening of
Ca^^ release activated channels (CRAC) of the plasma membrane [12]. The signaling
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molecules PLCyl, CaMKII, calcineurin, and calreticulin are all implicated in stimulating
Ca^^ influx through plasma membrane channels [8 ,

1 1 ].

Although it has been reported that integrin-ECM interactions lead to IP3 production,
no direct link between integrins and PLC activation has yet been established. A
convincing model of indirect activation, however, has recently emerged. In this model,
phosphatidylinositol-3,4,5-trisphophate (PIP3) interacts with PLCy, thus targeting PLCy
to the membrane and contributing to its activation. PIP3 is produced from PIP2 by the
action of phosphatidylinositol-3 kinase (PI-3K), an integrin associated kinase. Integrin
binding activates PI-3K through the activation of FAK [12]. Published data in support of
this model include demonstration that PI-3K regulates PLC mediated Ca^^ signaling [15],
PI3 kinase targets PLC to the membrane [16], integrin binding activates PI3 kinase, and
PI3 kinase promotes and is required for breast carcinoma invasion [17].
In this research, I identify three integrins expressed by the breast epithelial cells
MCF-lOA and MDA-MB-231 as potential receptors for intact laminin-1.1 show that
intracellular calcium flux is required for adhesion to laminin-1 , and that intracellular
calcium flux is dependent upon the type of matrix and integrin engaged. Furthermore, I
describe the production of six recombinant fragments of laminin-1 by baculovirus
expression system. Unfortunately, none of the recombinant proteins functioned as
efficient integrin ligands, and the potential causes of this result are discussed.
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Materiab and Methods
Calcium Detection
Cells were serum starved for 45 minutes and trypsinized until all cells had released
the substrate (-10 minutes). Trypsin was neutralized by 5mg/ml trypsin inhibitor
(Boehringer Mannheim, Germany) in DME. Cells were then washed in DME and held in
suspension for 30 minutes at room temperature in DME supplemented with 50mM
HEPES pH 7.4 and 5pM Fluo-3 AM (Molecular Probes, Eugene, OR). 120,000 cells
were plated per well in a 96 well plate coated as in adhesion assays with poly-L lysine,
matrix proteins, or anti-integrin antibodies. Fluo-3 fluorescence was measured over time
at 495nm excitation and 535nm emission in an automated fluorescent plate reader (Tecan
SPECTRAFluor, Research Triangle Park, NC) warmed to 37°C. Background auto
fluorescence of coated wells containing media only was subtracted from emission
fluorescence at each time point.
Virus construction
Domains of murine laminin-1 were amplified by polymerase chain reaction (PCR)
using sequence specific primers designed to generate single products with endonuclease
specific 5’ and 3’ ends (Table 1). Laminin-1 cDNAs were generously provided by Y.
Yamada [18]. The endonuclease digested PCR products were subcloned into the
pBACgus- 6 transfer plasmid (Novagen, Madison WI) in frame with the gp64 promoter,
secretion signal sequence, and either a 5’or 3’ 6 X Histidine repeat. The cloned product
was dideoxy sequenced in both directions to confirm proper insertion of the cDNA into
the multiple cloning site of the plasmid. Recombinant baculovirus was generated by
cotransfection of the pBACgus-6 /domain transfer plasmids with linearized baculovirus
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GTCGATTGCCTCAT
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Table 1. Construction of viral transfer plasmid. “CDNA” refers to the plasmid from which
the domain sequences were amplified. “RE” = restriction endonuclease. “Length”
indicates the size of the PCR product including overhangs which are removed following
endonuclease digestion. “Laminin-1 start” refers to the location within the native EHS
laminin-1 sequence vdiere the sequence encompassing the produced domain starts.
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(BacVector-3000 triple cut virus DNA, Novagen) into Spodoptera frugiperda 9 (Sfi)
cells maintained in Sf-900 n SFM media (Life Technologies, Rockville, MD)
supplemented with 10% fetal bovine serum (FBS, Gemini, CA), 100 U/ml penicillin G
sodium, and 100 pg/ml streptomycin sulfate (Life Technologies). Successfully
recombinant transfectants were identified by 5-Bromo-4-Chloro-3-indolyl-beta-DGlucuronic acid (Bio-World, Dublin, OH) digestion and purified by three rounds of
plaque purification. Cultured supemates.were analyzed for domain expression by
immunoblot analysis with anti-penta His monoclonal antibodies (Qaigen, Valencia, CA).
Transfected cell supemates were subsequently used to generate high-titer stocks of
recombinant viruses for future infections.
Protein production cmd purification
Sf9 cells were infected at >10pfii/cell and incubated at 29°C for 1-2 days in Sf-900 n
SFM media supplemented with 100 U/ml penicillin G sodium, and 100 pg/ml
streptomycin sulfate. Cells were collected and lysed in insect cell lysis buffer (lOmM
Tris-Cl pH 7.5,130 mM NaCl, 1% Triton X-100, lOmM sodium phosphate pH 7.5,
lOmM sodium pyrophosphate) supplemented with a 1:40 dilution of protease inhibitor
cocktail for use in poly (Histidine) tagged proteins (Sigma-Aldrich, St. Louis, MO) for
45min at 4°C and centrifuged at 10,OOOG for 45min at 4°C. Ni-NTA agarose beads
(Qiagen) were incubated in both cell lysate and cell supemate supplemented with ImM
Phenylmethylsulfonyl fluoride for four hours at 4°C and collected. Beads were pooled
and sequentially washed with forty volumes wash buffer (50 mM sodium phosphate, pH
8,

300 mM NaCl) supplemented with 80mM imidazole, and sixty volumes wash buffer

supplemented with 5mM imidazole. Protein fractions were collected in elution buffer (50
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mM sodium phosphate, pH 8,300 mM NaCl, 250 mM imidazole) and tested for purity by
silver staining (Silver Stain Plus, Bio-Rad Laboratories, Hercules, CA). Each domain
used in these studies was >95% pure. Typical yields ranged between 20-100 pg/L.
Adhesion Assies
Wells of a 96 well plate were coated for 1 hour at room temperature with laminin-1 or
recombinant proteins at the indicated concentrations in elution buffer (see above).
Negative control wells were coated for the same time in blotto (phosphate buffered saline
(PBS) containing 5% nonfat dry milk in (pH 7.4) and 0.1%Tween 20). Uncoated surfaces
were blocked by incubation at room temperature for 1 hour in blotto, and thoroughly
washed in PBS. Cells were trypsinized and resuspended in adhesion media (DME, 0.25%
heat-inactivated bovine serum albumin (BSA), 50 mM HEPES pH 7.4) at a concentration
of 2.4X10^ cells/ml. Cells were kept in suspension at room temperature for 30mins with
the indicated treatments. One hundred twenty thousand cells were plated per well and
incubated in a tissue culture incubator at 37°C for 30 mins. Non-adherent cells were
removed by gently rocking the plates upside down in PBS for 15 minutes. Adherent cells
were fixed for 15 minutes in 3.7% formaldehyde and stained for 15 minutes in 40%
methanol/0.5% crystal violet. Adherent cells were quantified by manual counting using a
20X objective or by measuring absorption at 595nm following cell lysis in 1%SDS.
Manual counting was used when it was desirable to preserve the plate for future analysis.
Using a 20X objective, cells were counted in a field that appeared to be 50% confluent
with cells. Cell number from other representative fields was compared to that number to
extrapolate percent confluence.
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Glycosylation Analysis
To determine the extent of glycosylation, approximately 2pg of each domain protein
was cleaved with peptide: N-Glycosidase F (PNGase F) (New England Biolabs, Beverly,
MA) according to manufacturers protocol and 0-Glycosidase (Roche, Indianapolis, IN).
For 0-Glycosidase cleavage, proteins were denatured for 10 mins at 100 C inO.lM PMercaptoethanol and 0.1% SDS. Alter cooling, samples were cleaved with 0.5 mU
enzyme in 10% NP-40,0.IM phosphate buffer pH 6 , and 500pg/ml bovine serum
albumin. All glycosidase reactions were allowed to proceed for 8 hoiurs at 37°C.
Immunofluorescence Microscopy
Coverslips were coated overnight at 4°C with laminin-1 or domain proteins in elution
buffer (see above). MDA-MB-231 cells were plated at a density of 6X10' cells/ml in
DME supplemented with 50mM HEPES pH 7.4 and 0.25% BSA and allowed to adhere
for 90 minutes at 37°C. Adherent cells were fixed with 3% paraformaldehyde and
permeabilized in 0.2% Triton X-100 for 15 minutes each. Non specific antibody binding
was blocked by 1 hour incubation with 3% BSA in PBS. Focal adhesions were visualized
by staining for one hour with 1:400 dilution of anti-vinculin monoclonal antibody (Sigma
Aldritch) in blocking solution followed by 1 hour incubation with 1:2000 dilution of
rhodamine-conjugated anti-mouse IgG secondary antibody (Molecular Probes, Eugene,
OR). F-actin was stained with 1:40 dilution of FITC-conjugated phalloidin (Molecular
Probes) following incubation with secondary antibody. Stained cells were visualized with
a Zeiss LSM confocal microscope using a40X objective.
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Statistics
Statistical significance was deteimined by the ANOVA/T-test with a 95% confidence
interval using JMP statistical software (Altura Software, Pacific Grove, CA).

Results
Integrin engagement stimulates varied intracellular calcium release
Cells engage ECM matrices with only a subset of expressed integrins, depending on
matrix specificity. Although there is some overlap, different subsets o f integrins are
engaged by each matrix. In order to determine if different matrices stimulate matrixspecific intracellular Ca"^ release, identical numbers of MCF-lOA cells were pre
incubated with a fluorescent cytosolic Ca^^ dye (Fluo-3 AM) and plated on different
matrix ligands. Emitted fluorescence was measured over time (fig. 1). Each matrix tested
caused the release of a unique concentration of cytosolic calciiun, and all were higher
than cells plated on poly-L lysine. This is presumably due to the subtypes and quantities
of integrins engaged. In order to demonstrate that simple clustering of integrin subtypes is
also capable of stimulating variable cytosolic Ca^^ flux, cells pre-incubated with Fluo-3
AM were plated in wells coated with antibodies directed against known laminin-1
binding integrins and intact lamiitin-1. Each of the integrins that influenced adhesion to
laminin-1 stimulated an intracellular calcium release that was different fi’om binding of
the intact molecule (fig. 2). These results suggest that signaling events downstream of
integrin activation synergistically determine the ultimate concentration of cytosolic
calcium release upon matrix engagement.
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Figure 1. MCF-lOA cells plated on the indicated substrates release different
concentration of cytosolic calcium over time. Serum starved cells pre-treated for 30
minutes with 5pM Fluo-3 AM were plated at a concentration of 120,000 cells per well
in wells of a 96 well plate coated with 20pg/ml of the indicated substrates.
Fluorescence was measured every 4 minutes in an automated fluorescence plate
reader at 37’C for the indicated time. The results of a representative experiment are
shown.
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Figure 2. MCF-lOA cell plated on anti-integrin antibodies release different
concentrations of cytosolic calcium over time. Assay conditions are
identical to figure 1. Error bars indicate standard deviation (p = 0.05, n = 4).
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Fluo-3 AM is a cell permeant dye whose excitation is increased upon binding free
calcium. The acetomethyl (AM) ester is cleaved in the cytosol, thus restricting the dye
fix)m entering intracellular calcium stores. While intracellular calcium release occurs with
release of distinct concentrations and with frequencies of distinct period [19], this dye is
capable o f measuring only total release of calcium over time under the conditions used
[20]. With a high affrnity for calcium, (Kd=325nM), this dye is likely to bind all free
cytosolic calcium [20]. Fluorescence measurements therefore reflect accumulation of
total calcium released by flux o f calcium release over time. The fluorescence
measurements reported are not likely to have arisen from changes in pH. The test media
was buffered (see materials and methods), Fluo-3 AM is non fluorescent in the absence
of calcium and is relatively insensitive to changes in pH. In fact, this dye is used with pH
sensitive dyes for simultaneous calcium and pH determinations [20, 21].
At the end of each

determination assay, cells were washed vigorously in PBS

and the number of cells remaining were counted as in adhesion assays (data not shown).
The number of adherent cells was roughly inversely proportional to cytosolic calcium
release. Laminin-5 is the preferred adhesive substrate of these cells [22], and caused the
least release of cytosolic calcium of all the matrices tested (Fig. 1). This suggests that
cells loosely adherent or actively migrating within the well released more frequent
calcium fluxes, or more calcium per release event.
MCF-lOA engagement to laminin-1.
To determine the binding properties of MCF-lOA cells on laminin-1, cells were preincubated with function blocking antibodies directed against integrins expressed by
MCF-lOA cells, a chelator of cytosolic calcium (BAFTA-AM), and the PI-3 kinase
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inhibitor wortmannin (Fig. 3). Cells were also incubated in heparin sulfate to demonstrate
that adhesion to laminin-1 is not dependent upon non-specific charged proteoglycanheparan interactions. Blocking integrins a l , a6, and pi inhibit adhesion o f MCF-lOA
cells to laminin-1 indicating that these are the primary integrins that determine the
strength of adhesion to lam inin-1. a6 is an integrin chain that can form a dimer with
either p 1 or P4 integrin chains. Because blocking P4 has no effect on adhesion (Fig 3.
Lane 14) a6 are binding laminin-1 in the a 6 p i configuration. Although not statistically
significant, blocking o3 appears to increase the strength of MCF-lOA cell adhesion to
laminin-l. Integrin o3 is included in these studies as a potential laminin-1 binding
molecule due to reports that a3 acts as a negative regulator of a6 activity in other cell
lines [3]. MCF-lOA engagement to laminin-1 is dependent upon cytosolic calcium as pre
incubation with BAPTA-AM abolishes adhesion (Fig. 3, lane 3). Integrin mediated
release of cytosolic Ca^^ is partially dependent upon the activity of Pl-3 Kinase as
wortmannin, a specific inhibitor of PI-3 kinase at the concentrations used, blocks
adhesion in a concentration dependent maimer (Fig. 3, lanes 4,5).
Laminin-1 domains as putative integrin engagement sites.
A comprehensive analysis of stmcture/function studies conducted with EHS laminin1 indicates that cellular fimction can be localized to distinct globular domains on each
arm of the laminin-1 subunits (Fig. 4) [23-50]. These studies were conducted with either
protease cleavage fragments of laminin-1 or small overlapping peptides derived from the
lam in in -1 sequence. Only rarely was a specific fragment or peptide implicated as a ligand

o f a specific integrin subtype. Because the large protease cleavage fragments are likely to
be bound by more than one integrin subtype, and because small peptides are unlikely to
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Figure 3. Properties of MCF-lOA adhesion to EHS laminin-1.120,000 cells
per well were plated with the indicated compounds in wells coated with
20pg/ml laminin-1. Ln-1 = laminin-1 alone, BAPTA = BAPTA-AM,
W = wortmannin. Error bars indicate standard deviation (p=0.05, n=8).
Diamonds indicate a significant difference from uninfluenced adhesion to
intact laminin-1.
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form conformations similar to the native molecule, I decided to produce several
individual domains in a eukaryotic expression system. The baculovirus expression system
was chosen for ease o f use, protein yield, and because proteins expressed in this system
are generally processed in a manner similar to vertebrate cells. Domains aVI (AVI),
alVb (AlVb), G l, G3, G4, and G5 were chosen due to the high probability of having
biological activity.
Production o f recombinant laminin-1 domains
Six proteins derived from the EHS laminin-1 sequence corresponding to specific
globular domains were produced. Based on silver-staining of protein elutions, each
protein was purified to greater then 95% purity (data not shown). Protein yields varied
from 2-lOpg/L. The molecular weight of each protein conforms closely to the predicted
size following cleavage of carbohydrate chains (fig. 5). All six proteins are glycosylated
via N- and not 0-linkages based on gel shifts following cleavage by pan-specific N- and
O- glycosidases.
Recombinant domains o f laminin-1 produced by baculovirus expression do not support
integrin mediated adhesion o f MCF-lOA and MDA-MB-231 cells.
In order to screen each recombinant protein as an adhesive substrate for epithelial
cells, MCF-lOA cells were plated in wells coated with purified proteins and intact
laminin-1. Due to low concentration of recombinant proteins, wells were coated with
equimolar amounts of protein (21 .InM), and not identical masses. Statistically reliable
adhesion to recombinant proteins by MCF-lOA cells was not demonstrated (Fig. 6).
Manganese, which acts to strengthen integrin engagement, did not influence MCF-lOA
adhesion to the recombinant proteins (data not shown). When pre-incubated with MCF-
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Figure S. Purified recombinant proteins. Proteins were visualized by western blot
analysis using anti-His antibody. All proteins are N- and not O-glycosylated as
demonstrated by gel shift following cleavage by PNGase F (B), or 0-glycosidase (C).
A = untreated.
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Figure 6. MCF-lOA cells do not reliably adhere to recombinant domains of laminin-1.
120,000 cells per well were plated in well coated with equimolar concentrations of intact
laminin-1 (20pg/ml) or recombinant domain proteins (0.3-lpg/ml). Error bars indicate
standard deviation (p —0.05, n=18). Diamonds indicate significant difference fiom
adhesion to laminin-l.
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lOA cells, no recombinant protein influenced adhesion to lam in in -1 (data not shown). In
order to determine if the failure to bind the recombinant domains was cell line-speciflc,
MDA-MB-231 cells, which bind to laminin-1 more strongly than MCF-lOA cells, were
also tested for adhesion. As indicated by pre-incubation with function blocking antiintegrin antibodies, MDA-MB-231 cells engaged laminin-1 with the a6|31 integrin (fig.
7, lanes 2-8). These cells did not, however, bind to proteins A6-G4 to any greater extent
than negative control (flg. 7 lanes 9-13). These cells did show significant adhesion to
protein G5. This binding, however, was integrin-independent as function blocking antiintegrin antibodies failed to influence adhesion (fig 7. Lanes 14-19). Curiously, MDAMB-231 adhesion to G5 was also independent of proteoglycan-heparan charged
interactions (fig 7, lane 20). This indicates that these cells engage protein G5 via a
member of another family of adhesion receptors, such as E-cadherin, a-dystroglycan, or
CD44.
Because epithelial cell adhesion to substrate normally results in formation of focal
complexes and spreading, MDA-MB-231 cells were incubated on laminin-1 and protein
G5 for 90 minutes, and visualized by fluorescence microscopy. Focal complex formation
was visualized indirectly with anti-vinculin antibody, and actin structure was visualized
by staining the actin cytoskeleton with fluorescein-conjugated phalloidin (fig. 8). MDAMB-231 cells spread and formed distinct focal complexes on laminin-1 (fig. 8, panel
A,B). On protein G5, adherent cells remained rounded and did not form any distinct
cytoskeletal structures or focal complexes (fig. 8, panels C,D).
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Figure 8. Morphology and focal conykx formation o f MDA-MB-231 cells adherent to
laminin-1 and protein G5. Focal adhesions o f cells adherent to laminin-1 (panel A) and
protein G5 (panel C) were visualized by staining for the focal adhesion marker vinculin.
Actin structure of cells adherent to landnin-1 (panel B) and protein G5 (panel D) were
visualized by staining with the F-actin binding molecule phalloidin.
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Discussion
Failure of the recombinant proteins to support adhesion may be due to altered
conformations, low concentration, or artifacts of the baculovirus expression system.
Because Sf9 are invertebrate cells, it is possible that the proteins are processed differently
than they would be by vertebrate cells. The baculovirus system, however, uses many of
the protein modification, processing, and transport systems present in higher eukaryotes,
including myristilation, palmitilation, phosphorylation, protein targeting, and cleavage of
signal sequences. A difference of concern, however, is that N-linked oligosaccharides in
insect cells are only high mannose type. They are never processed to the complex
oligosaccharides containing fiicose, galactose, and sialic acid seen in vertebrate cells.
This is only of concern if integrins require the presence of specific carbohydrate
structures for ligand recognition. Non-glycosylated laminins have been reported to be
adhesive [51], and non-adhesive (Y. Yamada, personal communication). 0-linked
glycosylations have been shown to occur in insect cells, but are less well characterized
[52,53].
In addition to altered glycosylation, the low yield of my system could also be
responsible for the lack of biological activity of these proteins. In the construction of all
recombinant viruses I chose the late gp64 promoter, as opposed to the more common
very late polyhedrin (polH) promoter. The gp64 promoter typically produces 60% the
yield of the stronger polH promoter but is active at a stage of viral infection when the
protein processing machinery required for efficient production of secreted proteins
remains intact [54]. The small size of the proteins (16-45kD) also contributed to low
yield when measured by weight, as smaller sequences are transcribed no more frequently
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than longer sequences preceded by the same promoter region. Small proteins stored at
low concentrations also tend to be less stable over time and less able to withstand freezethaw cycles. The low yield necessitated the use o f low concentrations for all assays. All
intact lam inin-1 was used at a concentration o f 20pg/ml, while each domain protein was
used at -l^ig/ml, which represents a 1:1 domain/intact laminin-1 equimolar ratio
(21.1nM). MCF-lOA and MDA-MB-231 cells, however, both adhered to laminin-1
plated at 21. InM to nearly the same extent as when plated in wells coated with 20pg/ml
laminin-1 (data not shown).
Although yield with the baculovirus system is unpredictable and varies greatly among
different proteins expressed, the yield in our system could be improved by double
infection o f sf9 cells with viruses containing the domain sequence downstream o f both
the polH and gp64 promoters. This strategy would extend the time of protein expression
during viral infection and take advantage of the stronger polH promoter, but would
require constructing, purifying, and amplifying an additional six viruses. A prudent
continuation of this work would be to produce proteins from the same DNA sequences
described here in another system that may provide a greater yield. Other protein
expression systems that may prove successful include direct transfection of bacterial.
Drosophila melanogaster, yeast, or mammalian cells.
The adhesion of MDA-MB-231 cells to protein G5 may be due to specific laminindystroglycan interaction. Dystroglycan is a heterodimeric integral membrane
glycoprotein receptor for several ECM molecules including laminins. It is expressed in
many epithelial cell types and binds laminin through G domains. In mice knockout
studies, it is shown that laminin-1, p i integrins, and dystroglycan are required at the same
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development stage, when the basement membrane first appears [55]. In addition, it is
demonstrated that dystroglycans have affinity for laminin in the low nanomolar range
[56].
The use of synthetic peptides is omitted here as a realistic model of integrin ligands.
Although they are widely demonstrated to effectively inhibit tumor cell adhesion to ECM
and other cells, stimulate anoikis, and decrease tumor cell métastasés in vivo, they are not
demonstrated to be activators o f integrin function. For example, the binding o f a peptide
that blocks adhesion to laminin is itself blocked by only the a6 and not the p i antiintegrin antibodies [23]. In addition, most integrins require either magnesium or calcium
in sites away from the binding domain. For this reason, integrin mediated adhesion is
typically blocked by EDTA. Adhesion to integrin binding synthetic peptides are not [23].
This data indicates that the peptides are functioning to block the integrin binding sites but
are not mimicking the binding to an intact native ligand. Lastly, the minimum size of
fibronectin derived peptide that still preserved the total binding activity is a fir^ment
with a molecular weight o f 75kDa [57].
While the recombinant proteins generated proved not to be reliable integrin
substrates, I believe that the generation of recombinant proteins that can activate specific
integrin subtypes by natural receptor/ligand interaction on a variety of cell types will be
valuable integrin research tools. I favor this strategy over the production of transfected
cells that express only defined integrin subtypes as recombinant cells expressing foreign
integrins may not have the cellular machinery required to propagate native integrinstimulated signals. In addition, recombinant domains would be more flexible research
tools as they could be used with several cell types as well as in different combinations.
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without having to produce doubly and triply transfected cell lines. Lastly, recombinant
domains could be useful for more than just the study of adhesion, but other functions
relevant to cancer progression including cell cycle control, prevention of apoptosis and
migration-associated tissue remodeling [58].
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CHAPTER 6

GENERAL DISCUSSION

My ultimate goal in studying integrin-mediated adhesion, migration, and signaling is
to identify targets for the design o f chemotherapies that function to inhibit the progress of
human cancers. Despite enormous efforts by clinicians and researchers, cancer is the
second leading cause o f death in the United States [1]. The five year relative survival rate
for all cancers combined is 59%. The National Institutes of Health estimate overall
aimual costs for cancer at $107 billion; $37 billion for direct medical costs (total of all
health expenditures), $11 billion for indirect morbidity costs (cost o f lost productivity due
to illness), and $59 billion for indirect mortality costs (cost o f lost productivity due to
premature death). Treatment of breast, lung, and prostate cancers account for over half of
the direct medical costs [1].
One of the primary reasons for the high morbidity of cancer is the frequent
ineffectiveness of currently available chemotherapeutic agents. Most cancer patients are
diagnosed at a time when métastasés are already evident. At this stage, surgery is never
effective at curing disease, and the patient requires adjunct chemo- and/or radiotherapy
[2].
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Although pathologically and clinically similar, tumors result from distinctive genetic
anomalies. For that reason, tumors with identical histologies can respond differently to
the same chemotherapies [3,4]. In fact, no single regimen has ever been demonstrated to
be effective in 100% of patients with a given tumor type. Most oncologists, however,
choose chemotherapy regimens based on standard tumor classifications obtained from
histology and empirical data from clinical trials. For this reason, patients frequently
receive treatments of no therapeutic value. These therapies are then altered until an
acceptable patient response is achieved. This process can be detrimental by prolonging
growth of disease, negatively influencing general patient health and morale, and
substantially increasing cost and length of medical care. In addition, many patients who
have a high probability of being completely refractory to chemotherapy treatment suffer
the side effects o f hopeless drug therapies [5].
Aside from early detection, there are two strategies for improving the morbidity of
cancer. One is to discover new classes of anti-cancer compounds that attack tumors in
unconventional ways. A second is to improve the efficacy of current therapies by
tailoring chemotherapy treatment for patients on a case-by-case basis. In order to
accomplish these tasks, assay systems need to be developed that can measure the
response of human tumors to chemotherapies, develop new techniques for relating
preclinical information to clinical results for prediction of future useful clinical agents,
and gain a greater understanding o f the specific molecular mechanisms that govern
cancer progression.
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Assay Development
At present, nearly all anticancer chemotherapies function to kill a patient’s tumor
cells. But the most dangerous cancer cells do more than grow: they metastasize by
migrating away from the initial tumor and spreading throughout the body. Because it
quantifies migration as well as cell death, the protocol described in chapter two has the
potential to be used as a high-throughput method for discovering novel anti-cancer
compounds that function to inhibit cell migration.
In addition, this assay has the potential to be used to tailor drug therapies for
individual patients. Distinguishing which population of patients will respond to a specific
drug before chemotherapy begins, can help the treating oncologist choose the best
therapy route. For example, only 20% of colon cancer patients respond to 5-fluorouracil
[6]. Patients whose biopsies are identified as sensitive to 5-fluorouracil have a much
better than 20% response and those patients whose biopsies are identified as resistant are,
depending on the assay, nearly always unresponsive. If the type of tumor being treated
has a low likelihood of response to chemotherapy, such as melanomas, NSCLS and GI
neoplasms, a biopsy test can help the oncologist decide whether to treat with
chemotherapy at all. If the type o f tumor typically does respond to chemotherapy, such as
breast, ovarian, and most small cell lung cancers, such a test will help select the most
effective, least toxic regimen. If the type of tumor is a generally "curable" cancer such as
hematologic neoplasms, the test will help determine the most potentially curative from
amongst comparable choices. Also, knowing when to stop treatment in hopeless
situations is as important as any other management issue [7,8].
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The technique of diagnosing a patient’s response to chemotherapy, before
chemotheTsq)y begins, is termed an In-Vitro Chemosensitivity Assay (IVCA) [9,10,11].
Unfortunately, the widespread use o f IVCA has been hindered by failures o f early assays
to predict patient outcome [10]. This could be due to the fact that all o f the currently
available FVCAs measure only the effectiveness o f drugs on blocking the growth of
malignant cells through quantification of cell proliferation, cell death, or production of

intracellular metabolites such as ATP. Therefore, the advantages o f the assay described in
chapter two also lend it to be used as an IVCA system that is potentially more pertinent,
sensitive, and effective than existing diagnostic methods. Convergence o f cell migration
and cell death data will minimize the occurrence o f false positive and false negative
responses, and improve the validity of true positive and negative responses. In addition,
this assay does not require cell cloning, a process that introduces bias by selecting
clonogenic cells fi‘om a heterogeneous biopsy.
The main argument against IVCA is that it has never been shown in prospective
randomized trials that there is a clear advantage to chemotherapy selected with the
benefit of knowledge o f the IVCA results compared to chemotherapy selected without
knowledge of the IVCA results [7,9]. This is not because studies were carried out and
failed to show a difference. It is because the studies have never been supported and
carried out by the NCI, NCI-CCCs and university cancer centers [10]. Arguments in
favor include that scores o f studies have consistently shown a significantly greater benefit
for treatment with drugs that are active in the tests compared to treatment with drugs that
are inactive in the tests. Additionally, a growing niunber o f studies have shown a superior
survival for patients treated with drugs that are active in these tests [10].
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Despite these successes, the full potential of IVCA has not yet been realized.
Problems associated with all IVCA techniques can essentially be summed up by stating
that no in vitro assay can completely duplicate in vivo conditions. For example, most
assays require that the biopsy cells are expanded in culture before testing. This allows
selective expansion of subsets of tumor cells so these assays may not be predictive of
responses of original tumor cells. Assays using differential cell staining techniques are
subject to individual interpretation, and frequently carmot distinguish live cells from
cellular debris. Measurements of cellular metabolism cannot discriminate cells that are
injured and will recover from those which are truly dead. Assays using cell proliferation
as the only valid endpoint have failed to predict clinical outcomes for cancer patients
[12]. Lastly, all assays that measure a single biochemical endpoint such as inhibition of
DNA synthesis may not accurately reflect cell survival, or may be influenced by cell
injury during tissue isolation. Nevertheless, assays such as the one described here need to
be continually developed and refined to fully realize a potentially valuable treatment tool.
Basic Research
A major problem facing researchers in the integrin field is that a large number of
intracellular molecules interact with integrins, yet no clear identification of their
individual functions is known. [13]. For example, focal adhesion formation is not always
required for integrin linked signaling, and when it is, proteins involved in numerous
signaling cascades are found at focal contacts [14].
In addition, it is difficult to differentiate the function of integrins. Integrin modulated
enhancement in metastasis formation may not be due directly to mechanisms of invasion,
but due indirectly through control o f the cell cycle and prevention of apoptosis. To
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further complicate matters, integrin function can be cell-type specific. For example,
different tumor cell lines can become more or less tumorigenic with up or down
regulation o f the same integrin [15]. The research presented here raises similar
conundrums.
In chapter three, I identify hsp27 as a factor which resists the effects of anti-migratory
compounds on integrin-mediated migration. Although it cannot be ruled out as a
promising chemotherapeutic target, this does not imply that hsp27 is a mandatory
constituent o f pro-migratory integrin-linked signal cascades. In addition to being an antiapoptotic agent, hsp27 can increase cellular resistance to heat shock and oxidative stress.
This protection is the result of several hsp27 actions. It is shown to be a molecular
chaperone, to interfere with caspase activation, and influence cytochrome C stimulated
signaling [16, S.W. Carper, personal communication]. Its action in migration may be an
indirect effect o f general survival functions.
In chapter four, I demonstrate that integrins can employ heterotrimeric G-proteins in
pro-migratory signaling. It is also known that G-proteins can mediate rapid activation of
the MAP kinases ERK 1/ERK 2 [17,18]. These kinases are integral to pro-migratory
signaling and are linked to integrin activation by at least two other separate pathways.
Heterotrimeric G-proteins can also influence the activity of FAK associated proteins such
as Src, and Pyk2 [19]. Does this imply that, like hsp27, G-protein activation is an indirect
consequence o f activation of diverse signal transduction mechanisms also involved in
pro-migratory signaling? It is also entirely plausible that integrins activate G-proteins by
directly stimulating G-protein coupled transmembrane receptors. It seems the only
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consistent truth is that cellular behavior is a consequence o f cooperation between multiple
signal molecules o f diverse function.
In order to understand the interrelationships and interdependencies between signal
molecules, the researcher must attempt to view a larger role for each molecule besides a
spot within a linear activation cascade. This trend is seen in the growth of the genomics
and proteomics fields, where a global cellular perspective replaces a single molecule
perspective. Once the activators and targets o f a kinase are discovered, it follows to be
discerned where and when specificity o f this signaling occurs. For second messenger
flux, such as intracellular ions, cAMP, or phospholipid bursts, the specificity arises firom
localization within the cell, concentration, and period [20-22]. For example, the catalytic
activity of CaMKII is higher upon exposure to calcium flux o f a faster period than a
slower one [23]. For catalytic enzymes, the specificity likely arises from complex
cooperation between target molecules that impact a similar cellular function.
Therefore, the questions that must be answered are: How does cooperation between
cascades govern cellular function? What are the critical junctions of this cooperation?
Would an upstream or downstream effector be the most successful target for
chemotherapy design or genetic manipulation? The hypothesis and model proposed in
chapter five attempt to provide an angle for answering these questions in the context of
integrin cooperation. While the recombinant proteins proved ineffective, this work
demonstrates that integrin cooperation does regulate a dynamic intracellular calcium
response. This dynamic response is almost certainly the result of intervening kinases and
other second messengers. It follows that more models need to be developed in the future
that will give us insight into the cooperative controls of cell behavior. Barring the
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discovery of scores more intracellular kinases, this will, in the author’s opinion, provide
the best explanations for the emergent properties of cell behavior.
The hypothesis presented in the general introduction o f this text states, “...laminin
binding integrins are capable of independently and simultaneously stimulating several
intracellular signal cascades that cooperate with one another to regulate the strength o f
adhesion and rate o f migration.” The data presented shows the involvement o f two more
proteins (HSP27 and heterotrimeric G proteins) in integrin-mediated adhesion and
migration not previously reported. A cooperation between integrin-stimulated signal
cascades is demonstrated in the regulation of intracellular calcium release reported in
chapter four. Furthermore, the partial inhibition of migration by specific inhibitors of
intracellular signal molecules (chapters 3,4), or adhesion by specific integrin blocking
antibodies (chapter 4), also strongly supports the dependence on communication between
integrin stimulated signals in the regulation of these activities. Future exploration of this
phenomena should include the production o f biologically active laminin domains
described in chapter five, followed by analysis of G-protein, HSP27, and intracellular
kinase activity in cells plated on those domains. The analysis made here predicts that
these proteins will be activated by specific integrins. Lastly, the activation state o f all of
those proteins at specific points in time will simultaneously control cellular adhesion and
migration.
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